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ABSTRACT
Consistency and Sensitivity Analysis of Multi-level Petri Net Models of
Biological Systems
Shauheen Zahirazami
Doctor of Philosophy Concordia University 2013
The recent developments in biological experiments have awarded the research com-
munity with valuable information, which describe finely regulated systems that govern the
cell dynamics. One of the greatest challenges, however, remains to represent this extensive
amount of knowledge in a proper way that can be used in simulations, and validated auto-
matically, in order to understand the dynamics and ultimately achieve a desired behaviour
for the system (cell) under control.
Many tools and techniques have been proposed in the literature to address this im-
portant problem. In this research, the use of Petri nets for knowledge representation is
investigated. The initial focus of this research is then to introduce a concept of consistency
between Petri nets obtained from various knowledge sources. Two algorithms are pro-
vided to construct Petri net models for cell dynamics using data available in public domain
biological database. The first algorithm generates a low-level model capturing protein-
protein interactions and the second, produces a high-level model which describes pathway
sequences and is considerably easier to analyze. Appropriate tests are developed to study
iii
consistency of such models.
In the context of biological systems, diseases that alter cell dynamics, such as cancer,
can be regarded as faults in the system, and disease diagnosis and treatment will correspond
to fault detection and control. In this research a framework has been proposed for sensitivity
analysis in Petri net representation of biological systems. Efficient tools and procedures are
developed to achieve sensitivity analysis. It is demonstrated using actual biological system
models, that the results of such analysis can be used as a basis of drug discovery.
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SOMMAIRE
Consistency and Sensitivity Analysis of Multi-level Petri Net Models of
Biological Systems
Shauheen Zahirazami
Doctor of Philosophy Concordia University 2013
Les de´veloppements re´cents dans des expe´riences biologiques ont de´cerne´ le com-
munaute´ de la recherche de pre´cieuses informations, qui de´crivent finement les syste`mes
re´glemente´s qui re´gissent la dynamique cellulaire. Un des plus grands de´fis, cependant,
reste a` repre´senter cette grande quantite´ de connaissance d’une manie´re approprie´e qui
peut eˆtre utilise´ dans des simulations, et valide´ automatiquement, afin de comprendre la
dynamique et, finalement, parvenir a` un choix comportement du syste`me (cellule) sous
controˆle.
De nombreux outils et techniques ont e´te´ propose´es dans la litte´rature pour re´soudre
ce proble´me important. Dans cette recherche, l’utilisation des re´seaux de Petri pour la
repre´sentation des connaissances est d’une enqueˆte. L’objectif initial de cette recherche
est donc d’introduire une notion de cohe´rence entre les re´seaux de Petri obtenus a` partir
de diverses sources de connaissances. Deux algorithmes sont fournis pour construire des
mode`les de Petri net pour la dynamique des cellules a` partir des donne´es disponibles dans
le domaine public biologique base de donne´es. Le premier algorithme ge´ne`re un mode`le
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de bas niveau de capture interactions prote´ine-prote´ine et la seconde, un produit de haut
niveau mode`le qui de´crit les se´quences de la voie et il est beaucoup plus facile a` analyser.
Les tests approprie´s sont mis au point pour e´tudier la cohe´rence de ces mode´les.
Dans le contexte des syste´mes biologiques, maladies qui modifient la dynamique des
cellules, telles que le cancer, peuvent eˆtre conside´re´s comme des de´fauts dans le syste`me,
et le diagnostic des maladies et traitement correspond a` la de´tection des de´fauts et de
controˆle. Dans cette recherche, un framework a e´te´ propose´e pour l’analyse de sensibilite´
dans la repre´sentation de Petri net de syste`mes biologiques. Des outils efficaces et des
proce´dures sont e´labore´es pour arriver a` une analyse de sensibilite´. Il est de´montre´ en util-
isant des mode`les de syste`mes biologiques re´els, que les re´sultats de cette analyse peuvent
eˆtre utilise´s comme base de de´couverte de me´dicaments.
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From a control engineering point of view, a cell of an organism can be considered as a
dynamical system, for which a proper controller can be designed in such a way that it en-
sures desirable behaviour. However the first step to design a proper controller would be
to model the system with an acceptable accuracy. In an electric motor (as an example of
a commonly used control system), the system specification can usually be expressed by a
list of about hundred design parameters from speed, torque, coupling type and frequency
to mounting type, insulation and shaft. However in the case of a cell, the specifications
required for modelling the system typically include over half a million chemical interac-
tions and more than hundred thousand genes. Furthermore, the knowledge of interactions
between biological entities is not completely available.
A very useful survey in applications of control in molecular systems biology is pre-
sented in [5] that illustrates the basic biological concepts and describes some open questions
in dynamics and control of this type of systems. One of the building blocks of biological
networks is protein interaction. Various types of interactions are orchestrated to achieve
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different objectives. Certain subsets of these interactions which construct a subsystem of
the metabolic network are known as pathways.
1.1 Problem Statement and Motivation
Due to the large size of the model of the cell, it is obvious that a systematic way of rep-
resenting the knowledge of the model is highly desirable. Many attempts have been made
to capture the dynamics of such systems using differential equations (e.g. [6], [7], [8], [9],
[10], [11]). While these models have proven to be very useful, the complexity of the non-
linear model obtained grows rapidly by the number of protein interactions involved. A de-
tailed approach which takes the entire cell dynamics into consideration will require a huge
model which is impossible to analyze. Furthermore, constructing such a model requires
fine knowledge of many coefficients that are either unavailable or very hard to obtain [8].
One approach to simplify the model with such a scale is to omit the continuous behaviours,
and construct a discrete event model (e.g. [12], [13], [14], [15], [16], [17]). Alternatively,
to capture more knowledge of the system, the use of hybrid automaton has been suggested
as a suitable modelling framework for biological protein regulatory networks (e.g. [18],
[19]).
Developing early detection methods, accurate prognosis and effective therapies for
numerous diseases such as cancer requires a system level understanding of the cell. It is
desired to have a framework that can be effectively used for modelling systems that are
knowledge-intensive. Such framework will be useful in analysis of biological systems
as well as financial, social and political systems. Furthermore, in order to influence the
behaviour of the system and achieve desired outcome, such model will provide a tool for
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control design.
As a simple example, think about an office, where an office assistant and a manager
are working. Both employees will take note of the events in the office. Now suppose that an
industrial or control engineer is trying to optimize the functionality of business processes
at this office. He will receive two logs of events one by the manager and the other by the
office assistant. Both of these logs describe the same system; however most certainly the
level of granularity is not the same, neither is the language. While the assistant may have
made a note about loading papers in the printer and preparing forms for purchase of new
batch of papers, the manager might have just noted approving a purchase. He might have
also noted the necessity to write a memo advising everyone to limit their use of the printer,
to save on paper budget.
Note that the high level log was not created by summarizing the low level notes. It
was rather generated by another observer who had a different perspective. It is desired
to study the consistency between the two logs. Also if a management (control) strategy
is designed based on the high level logs, it has to be ensured that the implementation in
the low level will also achieve desired behaviour. For instance, it has to be determined if
sending out a memo to everyone is the best solution for minimizing the consumption of
paper, or should the manager just cut access of a single heavy user instead.
The same type of problem can occur in social systems where for instance twitter
feeds and status updates on social networks could be an indication of certain major events
or reactions of different groups of people. As has been studied in case of flu epidemics
[20]. However there are other social indicators which could describe the same system from
other perspectives such as purchasing patterns or use of public transportation. The control
strategy here could be thought of as advertising campaigns or vaccination sponsorships, or
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even general alerts.
In the case of biological systems, proteins are the building blocks of the dynamics
of the system, and the concentration of proteins defines the state of the system. In such
systems a subset of proteins and their respective causal interactions which achieves a co-
herent functionality in the system (e.g. cell death) is a pathway [21]. In this case protein
interaction network is the low level language while pathway dynamics which is a functional
approach to the system is the high level. The control strategy here would translate into a
drug discovery method that would try to influence the behaviour of the biological system,
as has been studied in [22, 23, 24].
1.2 Research Objectives and Methodology
In this thesis a discrete event modelling framework has been proposed that allows efficient
representation of knowledge intensive models such as biological systems.
In this research three major issues are dealt with. The first step is development of a
model for cell dynamics. The developed model is the basis of all other steps and captures
the dynamics of the cell in a useful way. This model is then used for various different
knowledge sources that describe the same biological system with different levels of granu-
larity. Hence creating multiple models that describe the system with different languages.
The second objective is to analyze the consistency issues of the models. The goal
of this analysis is to identify new pathways or to provide new hypothesis for protein in-
teractions. Despite the wealth of available genomic data, there are still a lot of important
molecular interactions that are not yet completely observed. Such models have been used
to infer new information regarding the dynamics of the cell that have not been inspected
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experimentally or have been neglected due to physical obstacles. This analysis would also
be used in better understanding of the system behaviour as well as guaranteeing that a
controller designed based on an abstracted system could be used for a real system as well.
The third objective of this research is to study methods of designing proper con-
trollers. The controller design aims at avoiding failure states or recovery from failure by
altering the behaviour of the system. Here undesirable behaviour corresponds to diseases
and recovery to diagnosis and treatment. Designing a controller for such systems is specif-
ically challenging due to the limitations in the available methods of implementation. In
other words there is a certain class of interactions that can be regarded as controllable.
The methodology proposed is to conduct sensitivity analysis, which results in proper iden-
tification of target elements in the system that can be subject of biological tests for drug
discovery and design.
One of the major challenges of this thesis is lack of laboratory data for validation of
the models and parameters. It is very difficult to have the concentration of different proteins
while the biological entity is still alive (i.e. in-vivo) [25, 26, 27]. In this research publicly
verified mathematical models in literature were used to generate data and set parameters
[28, 29]. Finally the sensitivity results obtained with this framework are compared to the
similar results obtained using continuous models that are already verified in practice.
1.3 Literature Review
Some of the earliest documented works that mention automata date back to 1200 A.D. and
the works of a Kurdish scholar Al-Jazari. His manuscript titled “The Book of Knowledge
of Ingenious Mechanical Devices” and written in Arabic serves as a historical document
5
on the earliest automata ever used [30].
Figure 1.1: Diagram from book by Al-Jazari, (13th century AD) in the Suleymaniye Li-
brary [1]
The current literature surrounding the topic of discrete event systems in control can
perhaps be traced back to the works of Ramadge and Wonham [31, 32], which follows the
Eilenbergs study of automata in 1974 [33] and expands many works done in early 19th
century. This extensively helped shape the current state of supervisory control of discrete
event systems as is known today. On the other hand the study of Petri nets as a deviation
of graph theory was coined by Petri in 1962 [34] as a response to the ever growing need
to model industrial manufacturing systems. In the late 70s many researchers including
Tadao Murata worked on shaping a powerful literature for Petri net [35]. Perhaps the most
important work is Murata’s paper [36] that gathers and defines many aspects of what is
known today as the literature of Petri nets.
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A considerable body of knowledge exists on various tools and techniques for mod-
elling and control using Petri nets [37, 38, 39], which is an extremely valuable asset in any
attempt to solve problems and answer questions regarding automation and modelling of
discrete event systems. Refinement of Petri nets has been studied in various examples [40].
These methods have a bottom up approach, such that the refinement starts with a complex
system and then iterates to an abridged form [41]. Various researchers have studied the
problems of verification, or preservation of certain characteristics under such abstraction
mechanisms [11, 13, 42].
Petri nets have been specifically used to model chemical systems and their application
in modelling biological systems has received a lot of attention [7, 43, 44, 45, 46, 47, 48].
One of the clear advantages of such models is to provide a graphical representation of the
system that is easier to understand than differential equations. One major point in this type
of modelling is that the quantization of the chemical concentrations can effectively result
in a much faster and more efficient way of system analysis.
The study of biological systems using engineering tools and techniques has received
a lot of attention in the past few years. More specifically with various projects such as
the human genome project, new questions have been asked and are being answered. The
collective effort of many engineering and computer science research communities to solve
problems in biology is referred to as Systems Biology [5, 49, 50, 51, 52, 53, 54, 55, 56, 57].
Many tools have been used for modelling biological systems such as different Algebra [12]
and Petri nets [47].
One of the earliest works that uses Petri nets to model metabolic pathways was pub-
lished in 1993 by Reddy et al. [58]. The authors have used Petri nets to represent pathways
of biological systems primarily for qualitative analysis of the structure of the net. They
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further suggest some ways for simplification of the net to get rid of places and transitions
that are not integral in the structure of the Petri net.
This work was followed by other researchers who attempted at applying the same
idea to other cases such as gene regulation, biological regulatory networks, etc. [44, 45, 47,
48]. However two main problems constantly persists in the literature. First, the knowledge
of biological systems has been limited to biology literature which traditionally lacks the
same structure and coherence as engineering literature. This could in part be due to the size
of the problem as well as different methodologies in practice. Second, model validation
and simulation of the proposed systems has always been a big challenge partly because
biological data in general is extremely difficult or expensive to find. In many cases, tech-
nology has just recently reached a point of providing high quality, and high throughput
data. Nevertheless many attempts have been made to work on quantitative aspects of such
models [59, 60, 61].
These challenges have partly resulted in some of the attention to be shifted towards
analysis of isolated parts of the system [29, 62, 63], in the hopes that computer science
community would be able to create a more holistic approach to structure information in a
machine readable way [64, 65].
Limited availability of data has also resulted in many innovative approaches to sim-
ulate systems using other methods such as Monte Carlo [66]. A stochastic modelling
framework based on stochastic automata networks (SANs) for the analysis of complex
biochemical reaction networks has been studied in [55]. This approach takes into account
the discrete character of quantities of components (i.e. the individual populations of the
involved chemical species) and the inherent probabilistic nature of microscopic molecular
collisions. The SAN approach has the advantage of a modular design process making it
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adequate for abstraction purposes.
In [54] the author has studied biological pathway modelling based on hybrid intelli-
gent systems or soft computing technologies. Intelligent hybrid systems, refers to several
related computing methods such as fuzzy logic, neural nets, genetic algorithms, and statisti-
cal analysis. Considering biological pathways as complex control systems, which medicine
tries to manipulate to achieve desired results, hybrid intelligent systems may provide a use-
ful tool for modelling biological system dynamics and computational exploration of new
drug targets.
Apoptosis or the programmed cell death has been extensively studied in the literature,
both as a very important biological pathway [67] as well as a desirable example in systems
biology literature [68] due to incredible amount of information. Various proteins and el-
ements involved in this pathway such as p53 [69] or Caspase cascade [70] or IAP family
of proteins [71, 72, 73, 74, 75, 76] have been extensively studied. In particular XIAP has
been identified as a key element in treatment of many diseases such as cancer [77, 78]. This
system has been modelled and simulated in SimBiology, a MATLAB library for simulating
biological systems [28].
As the size of the model grows, the data available or generated becomes more and
more difficult to comprehend. Consequently it becomes inevitable to answer some ques-
tions regarding reachability analysis in Petri nets. One of the most important aspects of
studying Petri nets is the questions of decidability of various problems in reachability [79].
Many authors have proposed different methods to either avoid reachability analysis or to
at least reduce the burden of the complexity in their respective problems [80, 19, 81]. In
[82], the authors have studied decidability of various Petri net related problems including
reachability of different markings. A very extensive study of this problem is provided in
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[83], in which the authors survey complexity and decidability of model checking problems
using Petri nets.
The study of sensitivity analysis in ordinary differential equations is nothing new
[84]. This analysis has well been extended to hybrid Petri nets as well as Systems Biology
[85]. Perhaps the earliest such studies can be traced to [86], where the author speculates on
the future direction of control design in discrete event systems using perturbation analysis.
An in-depth survey was published on the state of perturbation analysis [87], however the
focus is on very simple queue like systems. In [88] authors study sensitivity in hybrid
stochastic Petri nets. The study of sensitivity in Petri net models of systems is either focused
on stochasticity or continuous analysis in hybrid Petri nets. Sensitivity of parameters in a
discrete sense has been mentioned in [89]. This concept has been studied for stochastic
Markov chain Petri nets in [90, 91]. Analysis of sensitivity in Petri net models of biological
systems had never been studied prior to this thesis, which is mostly due to novelty of the
research area.
1.4 Contribution of the Thesis
In this work, a framework has been developed that employs discrete event models to repre-
sent biological systems according to the available public domain biology knowledge bases.
The discrete event model used here is known as a Petri net, which is in the form of a bi-
partite digraph, where nodes are grouped in two groups known as places and transitions
and edges are called arcs. The dynamics of the Petri net is based on a token assignment
function. This function returns the number of tokens at every place of the Petri net at each
moment.
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Although the Petri net model developed for modelling protein-to-protein interactions
is very much easier to analyze compared to a continuous models, it can get very compli-
cated at the level of the whole cell. It will typically require more than half a million places
(in the Petri net), just to begin with, and a huge number of transitions.
The developed framework consists of at least two layers of knowledge abstraction
from different knowledge sources which are then analyzed for consistency. Note that this
can be easily extended to multiple layers. Hence the new high-level model that repre-
sents the sequence of pathway activations, rather than individual protein-protein interac-
tions is much smaller and easier to analyze. An algorithm is presented to construct the
high-level model from the pathway-to-pathway relation diagrams obtained from public do-
main knowledge bases.
Next the consistency of the low-level and high-level models is examined. Loosely
speaking, the high-level model is consistent with the low-level, if every pathway sequence
in the low-level is also possible in the high-level model. A necessary and sufficient con-
dition for modelling consistency is provided. The abstraction in the high-level model is
meant to simplify the understanding of the dynamics of the system while maintaining the
important characteristics of the low-level fine model. The high-level model may be used
in the development of control systems to affect the behaviour of the system. Note that the
two high-level and low-level models obtained this way have different sets of events and
obviously different languages, and a direct correspondence of the places and transitions are
not necessarily available.
An efficient method is then proposed to conduct sensitivity analysis on such discrete-
event models which can be extensively used in new drug discovery, along with computer
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simulation results, to complement or replace actual experiments. Note that these experi-
ments are very expensive in general, can raise ethical issues, and may take very long time
to achieve results.
Within the proposed framework the following key contributions have been made.
1. Construction of a multi-layer knowledge representation framework from various bi-
ological knowledge sources. This is in contrast with construction of multi-layer
systems using abstraction mechanisms, or bottom-up approaches, which in case of
knowledge intensive systems, such as biological systems has proven inefficient.
2. Defining consistency and developing an efficient method to evaluate consistency of
two models, as well as implementing appropriate MATLAB code library to execute
related evaluation tests.
• Definition of synchronous reachable marking, as a tool for comparison of lan-
guages generated by two machines with different alphabet.
• Definition of activation function, as a tool for mapping markings of high and
low level systems.
3. Defining sensitivity in the context of Petri net representation of biological systems.
• Introducing the notion of rigidity of places of a Petri net that helps measure
sensitivity.
• Developing two efficient methods to calculate the sensitivity without conduct-
ing full reachability analysis in a Petri net.
• Development of MATLAB library code for execution and evaluation of Petri
net systems, and visualizing the desired output.
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1.5 Organization of the Thesis
The rest of this document is organized as follows. In Chapter 2 the necessary background
on Petri nets and the biological knowledge is provided. First an overview of necessary
biological background including protein-protein interaction model (PPI) is briefly given.
Then formal definition of the Petri net is discussed. Next, some knowledge modelling tools
are briefly discussed and the shortcomings of some of the models to describe pathways
as well as building blocks of the models are analyzed. In Chapter 3 preliminary results
obtained for model construction is presented. A systematic method to construct the Petri
net model from a pathway diagram as well as an algorithm to create a high-level abstract
model for the system from pathway-to-pathway relation diagrams is shown. In Chapter 4
developments concerning the consistency of abstract and original models are investigated.
These results are accompanied by concrete solutions to overcome practical issues with
verification of the model, which is done using MATLAB codes and libraries. Chapter 6
investigates the issue of sensitivity in Petri net models of biological systems and presents
two methods for efficiently calculating sensitivity. Finally Chapter 5 concludes this thesis
and presents some possible future works.
1.6 Summary
This chapter provides an introduction to this thesis by introducing and motivating the prob-





This chapter covers background material necessary for the main developments of the the-
sis. First a brief background on systems biology is provided, next Petri nets are formally
introduced, and then modelling biological systems is briefly reviewed. Finally this chapter
is concluded with a brief overview of control of discrete event systems.
2.1 Systems Biology Background
The main objective of this thesis is to achieve a framework based on discrete-event models
for the application of engineering, modelling and analysis techniques to biological systems.
While in this thesis the discussion of biological details has been avoided as much as pos-
sible, it is necessary for the reader to have a basic understanding of some aspects of cell
dynamics. Interested readers are encouraged to consult relevant literature such as [22, 92].
The basic building blocks of the dynamics of a cell are the individual protein to
protein interactions. Almost every living organism has a DNA that serves as a genetic
blueprint for construction of various proteins. Biologists and bioinformaticians are trying
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to discover different relationships between more than half a million proteins, as one of
the most interesting and important areas of research in the post-genomic era. It is well-
known that the state of cell evolves when certain proteins interact with each other and
hence form different products which turn out to be proteins too and might involve in some
other interactions.
Combination of these sequences of interactions builds a metabolic network. While
the exact definition of a pathway inside a metabolic network is not straightforward [22], it
can be basically described as a subset of the network that has a distinguished function. A
cell constantly receives and responds to chemical signals from its environment. A signal is
initiated when some extracellular signalling molecule (ligand) binds with its respective cell
surface receptor. Signalling molecules inside the cell then interact to transduce the signal
into cellular responses. Specific collections of interconnected interactions in a network
are often referred to as pathways. Signalling pathways often consist of highly complex
networks, but it has been discovered that they are usually composed of typical building
blocks [22].
As an example let us consider the Apoptosis pathway. Apoptosis is known as one of
the main types of programmed cell death. Hence, it is a process of deliberate life relinquish-
ment by an unwanted cell in a multicellular organism. Any perturbation in the Apoptosis
pathway can result in a cancerous cell. In other words, when a cell, due to some DNA dam-
age for example, stops the programmed cell death, it starts reproducing in an uncontrolled
way. Recently research on Apoptosis pathway has grown widely. In addition to its impor-
tance as a biological phenomenon, defective apoptotic processes have been implicated in
an extensive variety of diseases. Too much Apoptosis causes cell-loss disorders, whereas
too little results in uncontrolled cell production. The P53 tumor antigen is a protein found
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in a wide variety of transformed cells and is a building block of the Apoptosis pathway
[69]. This protein is frequently mutated or inactivated in many types of cancer. P53 acts as
a tumor suppressor in many tumor types, and hence, its concentration in the cell can be a
parameter of interest while finding treatment.
The pathway used for case study in this thesis is the Caspase Apoptosis pathway.
Apoptosis is the genetically controlled process of programmed cell death that occurs in
multi-cellular organisms. This process is controlled by a diverse range of either extra-
cellular (extrinsic) or intra-cellular (intrinsic) signals. Such signals may regulate Apoptosis
positively or negatively. [28].
Apoptosis is fundamental in cells’ life cycle [67]. It allows the organism to control
cell population and to protect itself from morbid cells. In the process of Apoptosis, the nu-
cleus breaks into several discrete chromatin bodies due to the degradation of DNA, and the
cell membrane shows irregular buds known as blebs. The cell shrinks due to the breakdown
of the cytoskeleton by Caspases, and ultimately the cell breaks apart into several vesicles
called Apoptotic bodies, which are then consumed [67].
Mis-regulation or interference in Apoptosis can lead to several diseases, among which
are autoimmune diseases, neurodegenerative diseases, such as Alzheimer, Huntington and
Parkinson disease, and other diseases as AIDS and cancer [93, 94]. In all these diseases,
when the natural procedure of cell Apoptosis is interrupted due to any reason, the num-
ber of cells in a tissue start to increase or decrease in an uncontrolled way, the resulting
imbalance in the cell population leads to abnormalities in the tissue density [78].
Caspases play an important role in the Apoptosis procedure. Caspases are highly
conserved proteins that exist in two types: initiator Caspases among which are Caspase 2,
8, 9, and 10, and effector Caspases such as Caspase 3, 6, and 7 [70]. Initiator Caspases
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are only activated when binded to specific proteins. When initiator Caspases are activated,
they activate effector Caspases. It is these activated effector Caspases that then degrade a
host of intracellular proteins to carry out the cell death program [95].
X-linked inhibitor of Apoptosis protein (XIAP), also known as inhibitor of Apopto-
sis protein 3 is a member of the inhibitor of Apoptosis family of proteins (IAP) that stops
Apoptotic cell death [96, 71, 75]. XIAP stops Apoptotic cell death that is induced either
by viral infection or by overproduction of Caspases. It has a baculoviral IAP repeat (BIR)
domain [74, 72]. Inhibiting Caspase 3 activity, the BIR2 domain of XIAP binds to the
active-site substrate groove (where a protein substrate would normally bind during Apop-
tosis), blocking access of the normal protein substrate that would result in Apoptosis, as a
result, XIAP inhibits Apoptosis [97]. Figure 2.1 shows the mechanism of IAP mediation
in Caspase inhibition by XIAP [2, 74].
Minireview
807
Figure 1. Mechanisms of Caspase Inhibition by IAPs
(A) As revealed by the structures published earlier this month in Cell (Chai et al., 2001; Huang et al., 2001; Riedl et al., 2001), the linker region
N-terminal to the BIR2 domain of XIAP is a major structural determinant in binding to the active form of caspase-3 and -7. This complex may
be destabilized by the interaction of Smac/DIABLO with BIR2 due to a conformation change. Release of IAP complexed with Smac/DIABLO
would relieve the inhibition on the caspase and the active caspase is then free to induce cell death. (B) Caspase-9 inhibition by the BIR3
domain of XIAP requires the initial processing of the pro enzyme to expose the IAP binding motif at the N terminus of the small subunit
(Srinivasula et al., 2001). Once exposed BIR3 can bind to the IAP binding motif of caspase-9 and hinder the entry of substrate to the active
site of the enzyme. Smac/DIABLO competes with cleaved caspase-9 for binding to BIR3 and the binding partner then determines if the cell
undergoes apoptosis.
vasula et al., 2001 and Figure 1). Normally XIAP BIR3, BIR domain may help stabilize the interaction of the
linker with caspases or the linker itself maybe unstablewhich is specific for caspase-9, is unable to inhibit cas-
pase-3. However, engineering the four amino acid pep- in solution without additional sequences or domains for
maintaining conformation. The ability of GST to substi-tide into the N terminus of the caspase-3 small subunit,
allowed binding and inhibition by BIR3, suggesting that tute for the BIR domain supports this hypothesis. The
residues identified as important for caspase interactionthis four amino acid IAP binding motif is required for
inhibition by BIR3. Furthermore, the mutation of a single have some degree of conservation with the correspond-
ing residues of cIAP1 and cIAP2. What, if any, is theresidue (E314) in the BIR3 domain that is important for
Smac/DIABLO–IAP interaction abrogates the binding of mechanism of caspase inhibition by IAPs whose linker
sequences are distinct from that of XIAP? It is clearthe small subunit of caspase-9 to XIAP (Liu et al., 2000;
Wu et al., 2000; Srinivasula et al., 2001). This provides from the mechanism of caspase-9 inhibition that all BIR
domains are not created equal, as some possess theadditional evidence that binding and inhibition of cas-
pase-9 requires an intact BIR3 domain. ability to inhibit caspases by precise protein–protein
interactions mediated by conserved BIR binding motifs.What is the function of the BIR domain in inhibition
of caspase-3 and -7 by XIAP? Although the linker is Analysis of the structure of caspase-9 bound to XIAP
BIR3 would be useful to confirm the observation thatsufficient for the interaction of XIAP with caspase-3 and
-7, the second BIR domain plays a facilitating role. This BIR domains maintain the structural capacity to inhibit
Figure 2.1: Mechanism of IAP mediation in Caspase Inhibition by XIAP [2]
Caspase 3∗ is a protein that lices certain critical proteins at specific amino acid resid-
uals in the cell. Sequential activation of Caspase 3∗ plays a central role in the execution-
phase of cell Apoptosis. When the cell encounters a trigger, the level of Caspase 3∗ acti-
vation in the cell goes up, which means that the death signal (Apoptotic signal) is directly
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proportional to the levels of Caspase 3∗ activation in the cell. So, in this example, Cas-
pase 3∗ can be considered as the output of the system instead of the Apoptotic signal. The
goal is to determine which of the other proteins (inputs of the system) has the most effect
on the changes in Caspase 3∗ levels (and consequently on the Apoptotic signal) [28].
The diseases that effect the cell dynamics, (for example, cancer) can be regarded as
faults in the system (cell). Cancer is a class of diseases which is primarily characterized
by uncontrolled cell division and the ability of these cells to invade other tissues [92]. It
may be possible to use a control engineering approach for diagnosis and recovery (i.e.,
treatment) procedures for these faults. This is one of the main motivations of the research
reported in this research and will be discussed further in next section.
2.2 Petri Nets
Knowledge representation using Petri nets has been investigated in the past, e.g., [98], [99].
Reddy et al. [58] were the first to use Petri nets to model biological systems. They related
various mathematical properties of the Petri net to the biological properties of pathways
[58]. Shortly afterwards, Hofesta¨dt (1994) tried to adapt the Petri net formalism to more
adequately represent a biological system [43], and eventually designed a biological Petri
net model with simulation capabilities (Hofesta¨dt and Thelen, 1998) [51]. Even today,
their work reflects one of the two main goals of Petri net-based modelling methods: to
qualitatively study the structure and topology of metabolic pathways or to quantitatively
evaluate the dynamic behaviour of biological systems.
In this research, Petri nets are used to model cell dynamics. Petri nets are briefly
reviewed in this section. In a Petri net model, the edges are divided into two groups,
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namely places and transitions. No two places are connected directly to each other; no two
transitions are connected to each other either. Each place is assigned a number of tokens.
The number of tokens which is also called marking, describes the state of the Petri net.
A transition can fire only if the places connected to it have enough tokens to overcome
the weight of the arcs going from those places to the transitions. When a transition fires, it
takes some tokens from its inbound places and puts the tokens into the outbound places. As
a result, the state (marking) of the Petri net changes. For a complete survey of the literature
on Petri nets the reader is referred to [36] and [38].
Let Z+ denote the set of nonnegative integers. A labelled Petri net is a six tuple
G = (P,T,F,L,M0,Ω) where P and T are finite sets of places and transitions, respectively.
F is a flow function defined as,
F : (P×T )∪ (T ×P)→Z+ (2.1)
(For F(x,y)> 0, there is an arc from x to y denoted by A(x,y) with multiplicity F(x,y)).
For a transition t, Pre(t) denotes the set of places p with an arc to t (F(p, t) > 0).
L : T →Ω is a labeling (Labeling attaches an action name to each transition.) The definition
of L can also be extended to L : T ∗→ Ω∗, where Ω∗ denotes the set of finite sequences of
the elements of Ω, including the zero length string ε . For the Petri nets in this work, T =Ω
and L is the identity map. M0 is an initial marking of the Petri net, where a marking M
is a function that gives the number of tokens in each place defined as M : P → Z+. A
transition t is enabled at a marking M if for all p ∈ P, M(p) ≥ F(p, t), and is denoted by
M t→G. A transition t from a marking M to a marking M′ is denoted by M t→G M′, where
M′(p) = M(p)−F(p, t)+F(t, p) for all p ∈ P. Also for any a ∈ Ω, M a→G means M t→G
for some t with L(t) = a.
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The reachability set of a Petri net G is the set of all the states (markings) that can be
reached from a specific initial condition M0 and it is defined as,
RG(M0) = {M|∃σ ∈ T ∗,M0 σ→G M} (2.2)
The reachability can be calculated using different algorithms such as depth first search or
breadth first search [100]. A place p ∈ P is unbounded if,
∀k ∈ Z+ : ∃M ∈ RG|M(p)> k. (2.3)
A marking M is said to be coverable if there exists a marking M′ such that M′(p)≥M(p)
for each p in the net. A Petri net is said to be globally fair if every sequence σ ∈ L(M0) is



















Figure 2.2: Example of Petri net representation of Caspase cascade in Apoptosis
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2.3 Modelling Biological Systems
There are many different tools and techniques for representing pathway knowledge; e.g.
π-calculus, pathway logic, compound graphs and Petri nets [46, 101] .
It was suggested in [102] to use π-calculus for modelling biochemical networks as
mobile communication systems. In such a model, molecules and their individual domains
are treated as computational processes and their complementary structural and chemical
determinants correspond to communication channels [102]. Chemical interaction and sub-
sequent modification coincide with communication and channel transmission. A pathway
is defined as a collection of concurrently operating molecules, seen as processes with po-
tential behaviours.
In Pathway Logic, the syntax of an action language allows us to specify what the valid
states of the world are, how the world evolves from state to state due to execution of actions,
and what observations are made about the world [103]. The semantics of action languages
often formulate the notions of prediction, planning, explanation, and diagnosis. An action
theory is a collection of propositions written in an action language. An action theory can
be considered as a model of the world. For example, in the context of cellular modelling,
the world corresponds to the cell and a state is a snap-shot of the cell at a particular time.
In order to represent the protein-to-protein relationship, a graph model has been uti-
lized in the literature [104], [105], [106]. A comprehensive survey into the applications
of graphs and network characteristics (such as motifs), in biological modelling is available
in [107]. In this graph model, each protein or molecule is represented by a vertex of the
graph, while the possibility of an interaction between two proteins is shown by edges. In
the forthcoming discussions proteins can be regarded as proteins or other molecules whose
concentration may play a role in cell dynamics. The graph G(V,E) where V is the set of all
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proteins, and E is the set of unordered pairs of elements of V , can equivalently be shown
using a binary matrix. This network is also referred to as interactome [108].
Figure 2.3: The PPI network constructed on top of 11000 interactions from [3] involving
2401 proteins from S. Cerevisiae [4].
The combinatorial interactions among these proteins yield different possible out-
comes. While the graph model would present a great insight on investigating and studying
different diseases such as cancer, it does not represent any information about the outcome
of each individual interaction. In other words the first question would be what is the protein
assigned to each edge of the graph G. Hence, nodes are added to the graph model, which
represent the interactions. Furthermore the edges need to be directed.
To illustrate the Petri net model of biological systems, suppose that protein A and B
can interact and produce the compound AB, there would be two directed arcs from protein
A and protein B to interaction T and one arc from interaction T to the product protein AB
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(see Figure 2.4). The obtained bi-partite digraph is better known as a Petri net. A formal
definition of Petri nets was provided in the previous section.
Figure 2.4: A bipartite digraph representing protein interaction and its product.
In the Petri net model as a bipartite directed graph, the node classes represent “pro-
teins” and “reactions”, while the edges represent the possibility of proteins to enter into a
reaction. In this model, all steps of a pathway with all known details of the underlying reac-
tion mechanisms are represented. In order to generate the model, two classes of nodes have
to be constructed. The first class of nodes are the set of places denoted by P, which are all
proteins participating in the signalling pathways of interest. The second class is the set of
transitions denoted by T modelling interactions. Any interaction type can be fully encoded
with a list of substrates and products properly linked, thus explicitly specifying all molecu-
lar interactions. Subsequently, they are compiled as a predefined regulatory-interaction and
molecular-interaction candidates such as the ones given in Figures 2.5a to 2.6b [109]. Fur-
thermore, tokens in each place will represent the concentration of the respective biological
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entity represented by that place.
As an example, Figure 2.6a shows an enzymatic activation, where the presence of
enzyme C in the environment (i.e. tokens in place C) facilitates the chemical process from
A to B, and C remains intact after the process.
t
(a) Translocation A→ B
t
(b) Association A+B→ AB
t




(d) Enzymatic activation (inhibition) A+B ↔
C → D+A
Figure 2.5: Examples of Petri nets representing Translocation, Association, Dissociation
and Enzymatic activation for four proteins
While in some applications or references, the definition of the pathway could be
fuzzy, leading to difficulties in using the publicly available biological knowledge [110], in
this work, a pathway is an exact set of interactions obtained from public domain biological
knowledge-bases such as Kyoto Encyclopedia of Genes and Genomes (KEGG).
KEGG is a bioinformatics resource, developed as part of the research projects in
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Figure 2.6: Examples of Petri nets representing Inhibition and signalling cascade
the Kanehisa Laboratory of Kyoto University Bioinformatics Centre. As an example, the
Apoptosis pathway and the role of the protein P53 in this pathway, as described in KEGG,
can be seen in Figure 3.2. Notice that in order to capture maximum knowledge possible,
the pathway is represented by a block diagram with different types of connections. In order
to understand different types of interactions and events which are represented using various
forms of arcs, a legend table has been provided. This diagram specifies the starting points
of the pathway (i.e., cell surface receptors) through other interactions and up to where
the pathway completes, and triggers other pathways. A pathway-to-pathway relationship
diagram showing the causal effect of pathways on each other can also be obtained in terms
of tables of consequent pathways as discussed in Chapter 3, Section 3.1.2.
Petri nets were originally designed for modelling concurrent systems. As discussed
in the introduction, many extensions of the Petri nets have been used in modelling biolog-
ical phenomena. Petri nets in their various forms have proven to provide a powerful tool
for the purpose of modelling the knowledge of the cell, and hence coming up with its dy-
namical model [111], [17]. Efforts have been made to represent the biological knowledge
using Hybrid functional Petri nets [112], as extensions of functional Petri nets and hybrid
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object nets, by introducing continuous input and output arcs, and discrete and continuous
transitions, as well as simple hybrid Petri net models [59].
While most of these models can be converted to each other, it is to be noted that Petri
net modelling offers some advantages such as a well-established literature of supervisory
control as well as the rich tools of graph theory for analysis. In this research, Petri net
modelling of biological data has been studied.
While Petri nets in their various forms and definitions have been used for representing
biological systems, valuable analysis of these models are usually accompanied with other
high-level objects. It has been shown that executable high-level net models can lead to
several useful observations while low-level models can only result in a part of the desired
goal [113]. Therefore, alternative high-level models might become useful at times.
2.4 Supervisory Control of Discrete Event Systems
The control of discrete-event systems (DES) is an active research area, stimulated by the
objective of discovering general principles common to a wide range of application domains,
such as manufacturing systems, traffic systems, database management systems, communi-
cation protocols, and logistic (service) systems. The contributing specialities are notably
control, computer and communication science and engineering, together with industrial
engineering and operations research. With this variety of supporting disciplines, it is no
surprise that the DES research area embraces a large variety of problem types and mod-
elling approaches [114, 115, 116]
In a formal framework, a DES as a dynamic system, is equipped with a state space
and a state-transition structure. In particular, a DES is discrete in time and (usually) in
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state space. The DES model is asynchronous or event-driven, so that it is driven by events
other than, or in addition to, the clock ticks. A DES model can also be nondeterministic,
by having the capacity of transitional choices by internal chance or other mechanisms not
necessarily modelled by the system analyst.
The formal structure of a DES to be controlled is that of a generator (automaton)
in the form of a five tuple G = (Q,Σ,δ ,q0,QM), where Q is the set of states, Σ is the
finite alphabet of symbols which is referred to as event labels. δ is a partial function (pfn)
defining the transitions as δ : Q×Σ→ Q, q0 is the initial state and finally Qm ⊆ Q is the
subset of marked states. In the general sense, it is assumed that the alphabet Σ consists of
two disjoint components, namely, Σ=Σu∪Σc, where Σu represents the set of uncontrollable
events and Σc represents the set of controllable events.
The languages associated with the DES G are the closed behaviour L(G) and the
marked behaviour Lm(G) defined as follows.
L(G) = {s ∈ Σ∗|δ (q0,s)is defined}
Lm(G) = {s ∈ Σ∗|δ (q0,s) ∈ Qm}
In order to enforce a certain behaviour on the language generated by the system, a
particular subset of events to be enabled can be selected by specifying a subset of con-
trollable events. Normally all of the uncontrollable events will be added to this subset as
these are automatically enabled, and there can be no control over them. Each such subset
of events is a control pattern. Naming the set of all control patterns as Γ where Γ ⊆ 2Σ, a
supervisory control for G is any map V : L(G)→ Γ. The pair (G,V ) will be written V/G,
to show that G is under the supervision of V . The closed behaviour of V/G is denoted to
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be the language L(V/G)⊆ L(G) described as follows.
1. ε ∈ L(V/G)
2. If s ∈ L(V/G), σ ∈V (s), and sσ ∈ L(G) then sδ ∈ L(V/G)
3. no other string belongs to L(V/G).
The theory of supervisory control of discrete event systems then develops the notions
of supremal controllable sublanguage and optimal supervision as well as theories of fault
detection, isolation and recovery (see, e.g., [116], [117], [118], [119]). The general idea of
supervisory control can be applied to the Petri net models as well [38]. Since a bounded
Petri net can be easily converted to a finite state automaton (FSA), the results obtained and
tools available for automata can be applied to Petri nets as well.
2.5 Conclusion
This chapter provides the basic background that is used in the developments of this thesis.
A brief background in biology and Petri net modelling which is required has been covered.
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Chapter 3
Modelling Biological Systems Using
Petri Nets
This chapter covers the preliminary developments of the thesis. The main results on de-
velopment of a model for biological systems has been discussed. Also the methodology
is applied for obtaining two different Petri nets representing low-level and high-level sys-
tems. The aim is to provide a systematic framework for creating discrete-event models for
protein-protein interactions and pathway activation sequences based on a public domain
knowledge base.
3.1 Petri net Model Development For Biological Systems
3.1.1 Low-level Model Development For Protein Interactions
As discussed in the previous chapter, various pathway diagrams showing protein-protein in-
teractions have been obtained and are available from a number of databases such as KEGG.
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Figure 3.2 shows the Apoptosis pathway obtained from KEGG. Note that although the
sketch has been manually curated and hence, is highly accurate and readable to human, the
representation is not necessarily suitable to be taken as a machine knowledge representation
tool.
In this chapter, an algorithm is proposed that can translate a pathway block diagram
such as the one in Figure 3.2, to a Petri net model that efficiently describes the pathway
knowledge. The resulting Petri net can be understood and updated automatically, and
queried by a program. Furthermore, it can be studied using the tools and methods read-
ily available for the analysis of Petri nets.
Assume that all protein interactions are translocations (Figure 2.5a). Other types of
reactions can be easily accommodated as discussed later in Remark 1.
Algorithm 1.
Step 1. Construct a set I, consisting of the initial starting proteins in the pathway.
Step 2. Set j = 1.
Step 3. Choose a protein in I, call it p j, and set I= I−{p j}.
Step 4. Add a place p j in the Petri net set of places P if it has not already been added to
this set.
Step 5. Construct L, the set of all proteins directly connected to p j with an incoming arc
in the pathway.
Step 6. Set I= I∪ (L−P).
Step 7. For all pk in L if pk ̸∈ P, add a place pk in P.
30
Step 8. For all pk in L, create transition t j,k and corresponding arcs A(p j, t j,k) and A(t j,k, pk).
Step 9. If I ̸= /0, then set j = j+1 and go to Step 3; else stop the algorithm.
Algorithm 1 starts by constructing a set of initial points, and each time a protein is
encountered in the pathway block diagram and added to the Petri net model it gets deleted
from this set. In this way, all proteins that have been connected to it will be added to the
set. The Algorithm will eventually stop when all proteins and their respective interactions
have been examined and added to the Petri net. That is after the set I has only one member
whose immediate neighbourhood has already been added to the model. Therefore, after
Step 3 the set I becomes empty, and in Step 5, the set L is also empty or contains elements
that have already been examined. Hence, in Step 6, the union will cause I to remain empty
and the condition to exit the algorithm will be satisfied. The output of the algorithm is a
low-level model Glo. In the resulting Petri net, the tokens in each place would correspond
to the concentration of a protein and the transitions would represent protein-to-protein in-
teractions.
Remark 1. Step 8 of Algorithm 1 can easily be modified to: (i) incorporate a case de-
cision maker that constructs the transitions based on a lookup table, for different types of
interactions (as shown in Figures 2.5a-2.6b of Sec 2.3); and (ii) set different arc weights
based on the stoichiometric rate of different proteins in each interaction.
Example 1. Suppose that a simple (artificial) protein interaction network consisting of ten
proteins is given as shown in Figure 3.3. It is now desired to use Algorithm 1 to construct
a Petri net model of the network.
Table 3.1 shows the iterations of Algorithm 1. Columns +P and +T show the places
and transitions that are being added to the set of places and set of transitions in each
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Figure 3.1: Algorithm to construct the Petri net model from the pathway
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Figure 3.2: Apoptosis pathway obtained from the KEGG.
iteration, respectively. Also, the index that will be omitted from the set I at each iteration
has been crossed out.
The resulting Petri net is depicted in Figure 3.4. Notice that in a real example, the
names of proteins will most probably be stored in a database, and instead of protein names,
object ids will be used.
Following Algorithm 1, Petri net models can be constructed for various pathways,
which in turn, can be combined to form a large model. This model can be used in the
analysis of cell behavior or possibly be used in the development of supervisors to enforce
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Figure 3.3: Example of a pathway diagram to be converted using Algorithm 1. Only one
type of interactions (translocation) has been used.
a desired behavior (e.g., activation of the desirable pathways and disablement of the unde-
sirable ones). Even though this model is extremely useful, the number of places can get
very large, as we add different proteins to the model. Therefore, it is desirable to construct
a more abstract compact model that, for instance, describes cell dynamics at the pathway
level. A pathway level of abstraction is particularly useful since it is not uncommon for the
desired cell behavior (control specification) to be expressed in terms of pathways, rather
than the individual proteins.
3.1.2 High-level Model Development For Pathway Knowledge
As can be easily observed, the Petri net obtained by examining all pathways with proteins
involved in them would make a large model that would require a huge effort for analysis.
Therefore, it is highly desirable that an abstracted model be derived which preserves certain
characteristics of the original one and can be studied easier and with less computational
effort. As discussed in [120], reduction is defined as a validity-preserving transformation
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j I L +P +T
1 {1/ ,2,3} {4} p1, p4 t1,4
2 {2/ ,3,4} {5,6} p2, p5, p6 t2,5, t2,6
3 {3/ ,4,5,6} {5} p3 t3,5
4 {4/ ,5,6} {7} p7 t4,7
5 {5/ ,6,7} {8} p8 t5,8
6 {6/ ,7,8} {8} - t6,8
7 {7/ ,8} {8,9} p9 t7,8, t7,9
8 {8/ ,9} {4,10} p10 t8,4, t8,10
9 {9/ ,10} - - -
10 {10///} - - -
Table 3.1: Iterations of Algorithm 1 for Example 1.
that reduces a complex assertion into a much simpler one in such a way that the validity of
the latter implies the validity of the former. Pathway modelling using Petri nets is briefly
discussed in [109].
In order to proceed with the abstraction, it is desired to identify the subsystems within
the obtained model. The approach presented here considers each pathway as a subsystem
with a different functionality. However, instead of directly reducing the previously obtained
low-level model, the abstract (high-level) model is derived using the pathway-to-pathway
relation diagram available in databases such as KEGG. For instance, in KEGG the list of
all pathways triggered by each pathway is provided. In the case of the Apoptosis pathway,
for example, the list is as follows:
1. Cell communication
2. Neurodegenerative disorders
3. Calcium signaling pathway
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Figure 3.4: The resulting Petri net in Example 1
4. Cell cycle
5. Insulin signaling pathway
6. Type II diabetes mellitus
7. Type I diabetes mellitus
8. Alzheimer’s disease
9. Parkinson’s disease
10. Pathogenic Escherichia coli infection - EHEC
11. Colorectal cancer
12. Pancreatic cancer
The relation among pathways is represented in the form of a digraph which may
very well have loops. Furthermore, the causal effects of the pathways may change the
dynamics of the whole system. One advantage of not developing a high-level model from
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the low-level one is that the consistency of the two models can be examined through a
proper comparison method. (Details will be provided in the next section.) Inconsistencies,
if any, point to deficiencies or inaccuracies in the information used for setting up the low-
level and high-level models and to possible future experimental work necessary to correct
the inconsistencies.
In this section, an algorithm is proposed for translating pathway-to-pathway diagrams
into Petri net models. In the resulting Petri net, places represent pathways and transitions
represent completion of one pathway and preparation of the other. Hence, a pathway is
active when there are tokens in the respective place. Notice that there is no specific starting
point in the pathway-to-pathway relation diagram, and the algorithm finishes only when all
the knowledge has been captured.
Algorithm 2.
Step 1. Set j = 1 and I= {p1}.
Step 2. Choose a random pathway from I and call it p j.
Step 3. Remove the chosen p j from I.
Step 4. Add a place corresponding to p j in the Petri net set of places P and a transition t j
with an arc going from p j to t j.
Step 5. From the pathway relation graph, construct a set L of all the pathways resulting
from p j (i.e., with an incoming arc from p j) and a set B containing the pathways that result
in p j (i.e. with an arc incoming to p j).
Step 6. Set M= L∩P, and B= B∩P, and L= L−P.
Step 7. If B= /0 then go to Step 10.
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Step 8. Choose any pk from B, and add an arc A(tk, p j).
Step 9. Remove pk from B, and then go to Step 7.
Step 10. If M= /0, then go to Step 13.
Step 11. Choose any pk from M, and add an arc A(t j, pk).
Step 12. Remove pk from M, and then go to Step 10.
Step 13. Set I= I∪L.
Step 14. If I is not empty, then increment j and go to Step 2; otherwise stop the algorithm.
The algorithm finally stops when all pathways are examined, and the last pathway
either results in no other pathways, or all of its succeeding pathways have already been
added to P, in which case Step 6 makes the set L empty, and hence, in Step 13, the set I
will be empty and the condition to exit the algorithm is met.
The reduced high-level model Ghi obtained from Algorithm 2 does not consider in-
dividual transitions of the involved proteins; however, it describes the overall advancement
of the pathways in the cell. Therefore, based on an analysis of the simplified high-level
model, one would be able to draw valuable conclusions about the more complex low-level
model.
The tokens in the high-level model represent the activation of each pathway, it will be
shown in Chapter 4 that the tokens in Ghi can be determined based on the tokens in places
of Glo.
A high-level model would specifically be useful when designing a controller to alter
the cell dynamics (i.e. drug design). Towards this end, the high-level model could be used
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Figure 3.5: Algorithm to obtain high level model from KEGG
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to identify the chain of interactions that should be altered to obtain desired behaviour. Find-
ing new drugs could be interpreted as analyzing the system using known control methods
of discrete event systems (e.g. [119], [118]) to come up with a set of hypotheses that would
suggest what missing interactions facilitate or interrupt a certain pathway.
Example 2. A simple artificial pathway-to-pathway relation diagram consisting of six
pathways is given in Figure 3.6. It is now desired to use Algorithm 2 to construct a Petri
net model of the network. The resulting Petri net is depicted in Figure 3.7.
Figure 3.6: Example of an artificial pathway-to-pathway relation diagram to be converted
using Algorithm 2.
Table 3.2 shows the iterations of Algorithm 2. Notice that columns +P, +A and
+T represent the nodes and arcs that are being added to the Petri net sets. After the sixth
iteration, the set I becomes empty, and hence the algorithm stops.
A sample code to retrieve proteins and interaction from KEGG into MATLAB is
provided in Appendix A.1.1. This code uses the WSDL available on KEGG and can be
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j I L M B +P +A +T
1 {1/} {2,3,4,5} /0 {3/ ,6/} p1 p1 → t1 t1
2 {2/ ,3,4,5} {3} /0 {1} p2 p2 → t2
t1 → p2
t2


















Table 3.2: Iterations of Algorithm 2 for Example 2.
Figure 3.7: The resulting Petri net in Example 2
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used to retrieve all desired proteins, pathways and interactions of available organisms from
KEGG into MATLAB structures.
3.2 Conclusion
In this chapter two methods have been developed that will allow an efficient use of bio-
logical knowledge from publicly available knowledge sources, and construction of Petri
net models for a low-level protein interaction and high-level pathway relationship systems.
The issue of consistency of such models will be studied in the next chapter.
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Chapter 4
Consistency Analysis in Modelling of
Biological Systems Using Petri Nets
In this chapter the main developments regarding consistency analysis of multi-level Petri
net models of biological systems is provided. Two assumptions have been made to specify
weakly branched pathways. A notion of boundary transition has been introduced, as well
as pathway activation potential. Consistency of the high-level and low-level models in
capturing the dynamics is discussed.
4.1 Modelling Consistency
Suppose the two models Ghi and Glo have been obtained from two different knowledge
sources for instance following the procedures outlined in the previous chapter. It is now
desired to investigate whether the language behaviours of the two models can be directly
compared. Ghi is an abstract model of the system and captures the information about the
sequences of pathway activations in the cell. It is expected, at least, that every sequence of
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pathway activation that is feasible in Glo be also feasible in Ghi. In this thesis, this property
is referred to as modelling consistency. An important feature of the problem of comparing
Glo and Ghi is that they have different sets of transitions, and thus, their languages are
defined over different alphabets.
First, the notation in previous chapter is slightly modified such that the transitions
and places of Glo and Ghi are not confused. Let Plo, Tlo and Phi, Thi designate the place
and transition sets of the low-level and high-level models, respectively. The places in Glo
(elements of Plo) are shown by p and those in Ghi (which correspond to the pathways) are
denoted by v. The low-level transitions are denoted by t and the high-level ones by l. The
low-level and high-level markings are represented by Mlo and Mhi, respectively.
In order to study the consistency of the models, the following relations are defined.
Definition 1. Let RT ⊆ Tlo×Phi be a binary relation such that a pathway v ∈ Phi is in
relation with an interaction t ∈ Tlo (written as tRT v or (t,v) ∈ RT ) if and only if t can
happen while pathway v is active.
Definition 2. Let RP ⊆ Plo×Phi be a binary relation such that pathway v∈ Phi is in relation
with p ∈ Plo (pRPv or (p,v) ∈ RP) if and only if p is a protein that has a role in pathway v.
Remark 2. RT and RP could be set up according to the info from KEGG.
Definition 3. Define the set of boundary transitions that can trigger new pathways by Tb:
Tb = {t ∈ Tlo|∃v1,v2 ∈ Phi, p ∈ Plo,v1 ̸= v2 :
(t,v1) ∈ RT ,(t,v2) ̸∈ RT ,(p,v2) ∈ RP,F(t, p) ̸= 0}.
(4.1)
The following two assumptions are made about the boundary transitions.
Assumption 1. Each pathway can have at most one boundary transition.
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Figure 4.1: Example of a boundary transition.
Suppose Assumption 1 does not hold, and for instance, a pathway v can trigger an-
other pathway such as v′1 with boundary transition t1 and pathway v
′
2 with boundary transi-
tion t2. In this case, in order to be able to trace pathway activations at the high-level model,
the information that v may trigger v′1 or v
′
2 but not both at the same time, should be avail-
able in the high-level knowledge source, which may not be true in general (as in the case of
pathway-to-pathway relationship diagrams of KEGG). To ensure the assumption remains
valid, one may split v into two pathways: one triggering v′1 and the other v
′
2.
Assumption 2. A boundary transition belongs to one pathway only (pathways do not have
common boundary transitions).
Suppose Assumption 2 does not hold, and for instance, pathways v1 and v2 have
a common boundary transition t which triggers v′. In order to be able to correctly trace
pathway activations at the high-level, the information concerning the combination of the
two pathways v1 and v2 for triggering v′ must be available in the high-level knowledge
source. This information may not be available in general (as in the case of the KEGG
pathway-to-pathway relationship diagrams). In order to keep the assumption valid, one can
combine pathways v1 and v2 in a larger section with one boundary transition t.
The marking of a Petri net describes the state of the Petri net (as a dynamic system).
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In this case, any marking of Glo, such as Mlo, is a possible vector of protein concentrations
in the cell at a specific time. The concentration levels in Mlo will cause different pathways
to become active or inactive. For a given concentration of proteins (i.e. tokens in the
places) of the pathway v, the maximum number of times that the pathway v can trigger its
boundary transition in the absence of any external transitions (i.e. transitions not belonging
to the pathway) depositing tokens in the pathway places, is considered in this work as the
number of times the pathway v is activated.
Specifically, let Glo,v denote the sub-Petri net of Glo consisting of places and tran-
sitions of pathway v, and Mlo,v denote a marking of Glo,v. Furthermore, let L(Glo,v,Mlo,v)
denote the language generated by Glo,v starting from Mlo,v and tb be the boundary transi-
tion of Glo,v. Then the number of times v is considered activated at Mlo,v (or simply the
activation of v at Mlo,v), is
α(v,Mlo,v) = max{n ∈ N|∃s ∈ L(Glo,v,Mlo,v) : s contains n instances of tb}. (4.2)
The number α(v,Mlo,v) is, in fact, a measure of the potential of the pathway v to trig-
ger other pathways in the absence of any external transitions. Note that from the definition
of α that if as a result of an internal transition, Mlo,v becomes M′lo,v, then α(v,Mlo,v) ⩾
α(v,M′lo,v). In other words, in the absence of external transitions, the activation potential
does not increase.
At any given time, the set of the activations of all pathways simply translates to a
marking for the high-level model. In other words it is possible to define a function θ :
Mlo →Mhi, whereMlo andMhi represent the set of all low level and high level reachable
markings respectively, and the function θ maps any low-level marking Mlo to a high-level
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marking Mhi = θ(Mlo) with Mhi(v) = α(v,Mlo,v).
θ(Mlo) can be regarded as what the tokens of a high-level model should be, based on
the concentrations of proteins and the corresponding state (active/inactive) of the pathways.




lo) denote the initial markings of Glo and Ghi. M
0
lo is the
vector of initial protein concentrations, and M0hi gives the corresponding active pathways.
It is desired now to study the cell behaviour for a variety of initial states (markings).
Let Φ0lo and Φ
0
hi denote the set of all initial markings of interest.
In the study of the consistency between the low-level and high-level models, the low-
level markings that are reached as a result of boundary transitions play an important role in
establishing synchrony between the models.
Definition 4. A low-level marking Mlo is called a synchronous reachable marking with
respect to the initial marking M0lo if Mlo is either equal to M
0
lo, or Mlo can be reached from
M0lo through a sequence of transitions in which the last transition is a boundary transition.
Denote the set of synchronous reachable markings with Rs(M0lo). One can write
Rs(M0lo) = {M0lo}∪{Mlo|∃s ∈ T ∗, tb ∈ Tb : M0lo
stb→Glo Mlo}. (4.3)
Notation 1. For two low-level markings Mlo and M′lo, and a boundary transition tb ∈ Tb,
the notation Mlo
tb=⇒Glo M′lo is used if either Mlo
tb−→Glo M′lo or Mlo
t1,...,tntb−→ Glo M′lo, where
ti ̸∈ Tb(1⩽ i⩽ n).
Therefore, Mlo
tb=⇒Glo M′lo if M′lo can be reached from Mlo through a sequence of tran-
sitions in which the last transition is the boundary transition tb and the rest of the transitions
are not boundary transitions.
The notion of consistency is formally introduced next.
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Definition 5. Ghi is called consistent with Glo with respect to an initial marking M0lo if
for any Mlo,M′lo ∈ Rs(M0lo), the relation Mlo
tb=⇒Glo M′lo for some tb ∈ Tb implies that (i)
there exists a reachable high-level marking Mhi with Mhi ⩾ θ(Mlo), and (ii) for any such
high-level marking, there exists another high-level marking M′hi, with M
′
hi ⩾ θ(M′lo) such
that with a single high-level event Mhi →Ghi M′hi.





Note that Mhi ⩾ θ(Mlo) means every element of Mhi is greater than or equal to the
corresponding element in θ(Mlo).
Definition 6. If Ghi is consistent with Glo for every initial marking in the set of initial
markings Φ0lo, then Ghi is said to be consistent with Glo.
The high-level model is developed to summarize the information about the sequence
of activated pathways. Essentially, Ghi is consistent with Glo if any sequence of pathway
activations at the low-level can happen at the high-level (but not necessarily vice versa).
The models will not be consistent if a behaviour (i.e. pathway activation sequence) at the
low-level is not captured in the high-level model.
Remark 3. It follows from Definition 5 that in the low level model a pathway may not be
able to fire a boundary transition triggering another pathway, while in the high level the
corresponding pathway may have enough tokens to fire the transition to trigger the other
pathway. (This may happen when M′hi > θ(M
′
lo)). This will be demonstrated in Example 4.
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It is desired now to develop a procedure for verifying consistency. In the supervisory
control framework as introduced by Ramadge and Wonham, relationships between different
languages, such as bisimulation, have been investigated [121]. Equivalence and refinement
relations based on bisimulation and simulation relations between two DES models look for
the pairs of states (Petri net markings) that can be reached after the occurrence of identical
strings. However, in the problem discussed here, Glo and Ghi have completely different
transition sets (i.e. alphabets). To study and verify the property of consistency, a mapping
from the sequences of the low-level model to those of the high-level one is needed. This
mapping is performed using an intermediate Petri net Gmi whose places belong to Ghi and
transitions are from Glo. Specifically, from the procedure of construction of Ghi (Chapter 3,
Section 3.1.2), it follows that for every high-level transition t, there exists an input place
(pathway) v with an arc from v to t (i.e. Fhi(v, t) ̸= 0).
Definition 7. Gmi is obtained from Ghi by simply replacing every transition t in Ghi by
the boundary transition of its input place (i.e. pathway) v. If Pmi and Tmi denote the set of
places and transitions of Gmi, then Pmi = Phi and Tmi ⊆ Tb. Furthermore, the initial marking
M0mi is defined to be M
0
hi, which is equal to θ(M
0
lo).
An example of the model Gmi and its relation with Glo and Ghi can be observed in
Figure 4.3.
It is now useful to define the following relation between the languages generated by
two models, where natural projection is used as defined in [114].
Definition 8. Consider two Petri nets G1 and G2, defined over alphabets Ω1 and Ω2 with
Ω1 ⊆Ω2. The language L(G1) summarizes (in the sense of abstraction) L(G2) with respect
to alphabet Ω1 denoted by L(G1)≾ L(G2) if ΘΩ1(L(G2))⊆ L(G1), where ΘΩ1 : Ω2 →Ω1
is the natural projection of Ω2 onto Ω1.
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Figure 4.3: Combined models, Glo, Ghi and Gmi, with some of the arcs shown. The arcs of
Gmi are shown in dashed lines.
The natural projectionΘ drops all characters that do not belong toΩ1 (i.e., characters
in Ω2−Ω1). In the above definition, model G1 can be regarded as an abstraction of G2,
providing summary information about the occurrence of the events of Ω1 only. Note that
this abstraction is conservative in the sense that L(G1) may contain sequences that are not
the projection of any sequence in L(G2).
The following theorem establishes a necessary and sufficient condition for the con-
sistency of Ghi with Glo, with respect to a given initial condition M0lo.
Theorem 1. Ghi is consistent with Glo with respect to an initial marking M0lo if and only if
L(Gmi)≾ L(Glo).
Proof: First assume that the two models are consistent. It is desired to show that L(Gmi)≾
L(Glo) or ΘΩmi(L(Glo))⊆ L(Gmi).
Suppose that s∈ L(Glo). IfΘΩmi(s) = ε , thenΘΩmi(s)∈ L(Gmi). IfΘΩmi(s) ̸= ε , then
let ΘΩmi(s) = t
1





t2b=⇒Glo · · ·
tmb=⇒Glo Mmlo
By definition M0hi := θ(M
0
lo). Thus consistency implies that
∃M1hi ⩾ θ(M1lo) : M0hi →Ghi M1hi
Also,
∃M2hi ⩾ θ(M2lo) : M1hi →Ghi M2hi
Similarly there exists M3hi such that M
2
hi →Ghi M3hi, and so on. Thus,
M0hi →Ghi M1hi →Ghi · · · →Ghi Mmhi
and with Mimi := M
i
hi for 0⩽ i⩽ m,
M0mi
t1b−→M1mi
t2b−→ ·· · t
m
b−→Mmmi
and hence t1b · · · tmb ∈ L(Gmi), which shows that ΘΩmi(s) ∈ L(Gmi).
Conversely, it is desired to show that ΘΩmi(L(Glo))⊆ L(Gmi) implies consistency. In
other words, if for any s ∈ L(Glo), ΘΩmi(s) ∈ L(Gmi), then the models should be consistent.
Suppose M0lo
tb=⇒Glo M′lo. Then either M0lo
tb−→Glo M′lo or there exists t1, · · · , tm ̸∈ Tb such
that M0lo
t1···tmtb−→ Glo M′lo. This implies tb ∈ ΘΩmi(L(Glo)), and therefore, tb ∈ L(Gmi). Thus
there exists M′mi such that M0mi = θ(M
0
lo)
tb−→Gmi M′mi. We claim M′mi ⩾ θ(M′lo). Otherwise,
there exists a pathway v such that M′mi(v) < θ(M′lo)(v) or in other words, M
′
mi(v) is less
than the activation of the pathway at M′lo. Let t
′
b be the boundary transition of v and n the
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activation of v when Glo is at M′lo. Then tbt
′n
b ∈ ΘΩmi(L(Glo)) but tbt ′nb ̸∈ L(Gmi) which
contradicts the assumption. Thus we have M′mi ⩾ θ(M′lo). This implies that in Ghi, M0hi =
M0mi = θ(M
0
lo)→Ghi M′hi = M′mi ⩾ θ(M′lo).
Similarly, if Mlo ∈Rs(M0lo), then M0lo
stb−→Glo Mlo andΘΩmi(stb) = t1b , . . . , tkb . Therefore
t1b , . . . , t
k




b−→ Gmi Mmi. Using an argument similar to that in the previous paragraph,
one can show that Mmi ⩾ θ(Mlo). For any t ′b where Mlo
t ′b=⇒Glo M′lo one can conclude




b ∈ΘΩmi(L(Glo)) and therefore t1, . . . , tb, t ′b ∈ L(Gmi). For any marking such
as Mmi, there exists another marking M′mi with Mmi
t ′b−→Gmi M′mi. It can be observed that
M′mi ⩾ θ(M′lo). Proof can be established by noting that each time a boundary transition
fires, tokens in a high-level place will be reduced by one, while the activation in the low
level model will be reduced by at least one and possibly more, therefore M′mi⩾ θ(M′lo).
Remark 4. If L(Gmi) ≾ L(Glo) does not hold, it could be conjectured that for the specific
pathways that the relation does not hold, incomplete knowledge has been used in construct-
ing the model. Such cases would be candidates for further lab tests.
Remark 5. The condition in Theorem 2 involves projection of languages and can be veri-
fied (assuming bounded Petri nets and thus, regular languages), by for example converting
the Petri nets to automata and using operations on automata.
Example 3. To demonstrate the results, suppose that two pathways v1({p1, p2, p3},{t1, t2})
and v2({p4, p5},{t3}) consisting of five proteins and three interactions are defined as de-
picted in Figure 4.4. As can be observed, the transition t3 is a boundary transition between
pathways v1 and v2. An initial marking M0lo = [p1, p2, p3, p4, p5]
T = [0,1,1,1,1]T is given
for Glo. Hence, L(Glo) = {t2t3t1t2, t3t1, t2t2, t3t2t1t2t1t2, t3t2t1t1t2t2}. The initial state of Glo
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will result in the initial state M0hi = [1,0]
T for Ghi, where pathways v1 and v3 are active.
Note that the activation of v2 is zero since v2 does not have any boundary transition to fire.
Observe that Thi = {l1}. Gmi is the same as Ghi with l1 replaced by t3. Thus L(Ghi)= {ε, t3}.
Therefore ΘΩmi(L(Glo)) = {ε, t3} = L(Gmi), which means Ghi is consistent with Glo, with
respect to M0lo. Any string generated by Gmi will then have only one t3, and no more t3’s
will appear afterwards. This is consistent with the language generated by Glo.
Figure 4.4: Petri net example of the high-level and low-level models. The arcs of the middle
model are shown using dashed lines.
Example 4. Suppose that two pathways v and v′ are defined as depicted in Figure 4.5.
Pathway v contains three proteins p1, p2 and p3, and three interactions t1, t2 and t3. Transi-
tion t3 is also a boundary transition that activates pathway v′. Pathway v′ contains protein
p4 and interaction t4.






Figure 4.5: Petri net example of two sample pathways v and v′
Mlo =

1 1 0 0
T
. Then
L(Glo,v,M0lo,v) = {t1t3, t2t3t1t3, t2t1t3t3}
L(Glo,M0lo) = {t1t3t4, t2t3t4t1t3t4, t2t3t1t4t3t4,t2t3t1t3t4t4, t2t1t3t4t3t4, t2t1t3t3t4t4}
ΘΩmiL(Glo,M
0
lo) = {ε, t3, t3t3}
(4.4)
It follows from (5.12) that α(v,M0lo,v) = 2, α(v






From the perspective of Glo, the occurrence of the events t1t3 will drive the ini-




0 1 0 1
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. From the perspective of Ghi, firing the boundary









This suggests that in the high level model, pathway v can still fire while in the low level,
v will no more be activated. Notice that this does not violate the condition for consis-
tency of the model since consistency requires that the high-level model be able to generate
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all pathway sequences possible in the low-level but not vice versa. To capture more ex-
act dynamics (making ΘΩmi(L(Glo,M
0
lo) closer to L(Gmi,M
0
mi)) the knowledge source for
the high level should be enriched. Meanwhile the language of Gmi can be obtained as
L(Gmi) = {ε, t3, t3t3}, which proves consistency between the two models.
4.2 Biological Case Study
In order to validate the theory developed in this work, a real biological system is studied.
The pathway used in this study is the Caspase Apoptosis pathway. Apoptosis is the geneti-
cally controlled process of programmed cell death that occurs in multi-cellular organisms.
This process is controlled by a diverse range of either extra-cellular (extrinsic) or intra-
cellular (intrinsic) signals. Such signals may regulate Apoptosis positively or negatively
[67, 74, 78].
Apoptosis is fundamental in cells’ life cycle [67]. It allows the organism to control
cell population and to protect itself from morbid cells. In the process of Apoptosis, the nu-
cleus breaks into several discrete chromatin bodies due to the degradation of DNA, and the
cell membrane shows irregular buds known as blebs. The cell shrinks due to the breakdown
of the cytoskeleton by Caspases, and ultimately the cell breaks apart into several vesicles
called Apoptotic bodies, which are then consumed [67].
This system has been extensively studied, the equations governing the dynamics of
apoptosis can be found in literature, more specifically it has been studied using SimBiology
for MATLAB [28]. Figure 4.6 shows this model in SimBiology diagram environment. The
parameters of the system are then exported as a matrix that is used to build a Petri net model

















Figure 4.6: Simbiology Model for Casp3 in Apoptosis.
Note that the dynamics of a drug controlling the Caspase cascade is also introduced.
In this way three main subnets can be identified, as shown with different colours in the
Figure 4.7. These three subnets can be modelled as three separate high-level systems. In
this case t11 is considered as the boundary transition for the drug dynamics subnet, t10
is the boundary transition for the XIAP subnet and t1 is the boundary transition for the
Caspase cascade subnet. Hence the low-level model will consist of all protein interactions
that are involved in Caspase cascade regulation system, and the high-level model consists of
Caspase cascade as well as XIAP subnet and drug dynamics. Note that both Assumptions 1
and 2 are true in this example.
Figure 4.8 shows a high level model for this system.
It is also possible to consider the reversibility of some interactions which could lead
to a high level system as depicted in Figure 4.9.













































Figure 4.8: High level model of the system depicted in Figure 4.7, constructed from bio-











Figure 4.9: High level model of the system depicted in Figure 4.7, constructed from bio-
logical knowledge, with reversible effect.
and then generate the state space for the system. In choosing a reasonable initial condi-
tion here two things have been taken into account. First using small values, for units of
concentration results in many tokens and hence a large state set. At the same time, the
tokens should be enough such that every transition gets to fire at least once. Second the rel-
ative number of tokens at various places are matched to those of simulations in SimBiology
examples. Initially suppose that
M0lo = [3,0,0,0,0,0,5,3,0,0,0,0,1].
Starting from this initial condition, the state space of the low-level system is calculated and
state transition diagram is depicted in Figure 4.10. Note that this rather small initial con-
dition generates 175 states. Let L ↑ denote an element-wise largest value for the reachable
states, and L ↓ denote the smallest element-wise value for the reachable states. R(Glo,M0lo)
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has the following statistics,
L ↑ (R(Glo,M0lo)) = [3,3,3,0,0,3,5,3,3,1,1,1,1]
L ↓ (R(Glo,M0lo)) = [0,0,0,0,0,0,1,0,0,0,0,0,0]



































































































































































































































































































































































































































































































































































































































































































Figure 4.10: Low level system with 175 states.
Next one more token is added to ensure that all transitions in the system will fire at
least once. The new initial condition is as follows
M0lo = [3,0,0,0,1,0,5,3,0,0,0,0,1].
This initial condition will result in 405 states. The state transition diagram is shown in
Figure 4.11. Note that as state space grows it gets more difficult to interpret the state
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diagram of the low-level system. R(Glo,M0lo) has the following statistics,
L ↑ (R(Glo,M0lo)) = [4,3,3,1,1,3,5,3,3,1,1,1,1]
L ↓ (R(Glo,M0lo)) = [0,0,0,0,0,0,1,0,0,0,0,0,0]






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.11: Low level system with 405 states.






lo,v), the initial condition of the high-
level system is obtained as M0hi = [3,1,1].
The high-level system as depicted in Figure 4.8, generates 8 states as shown in Fig-
ure 4.12. Note that for consistency, the high-level model needs to be able to produce the full
behaviour of the low-level system and perhaps more. It can be easily verified (i.e. simple



























Figure 4.12: High level system with 8 states and M0hi = [3,1,1].
consistency. Also if the low-level initial condition M0lo increases, resulting in an increase in
M0hi since Mhi(v) = α(v,Mlo,v), still consistency is satisfied. The results for M
0
hi = [6,2,2]
is shown in Figure 4.13.
Now suppose that the high-level system is modelled as in Figure 4.9. Starting from
the same initial condition M0hi = [3,1,1], the output of the system is then obtained and
shown in Figure 4.14. The black dotted lines represent a transition back to a previous state
on the left, as l1 and l3 are in reverse directions. The high-level system is again consistent
with the level system with respect to the initial condition M0lo.
Note that adding tokens to a place such as V2 will still result in consistency, in which
l2 occurs only once in any string generated and l1 can occur many times in any string
generated by the system.
It can be observed that the high-level models are much easier to work with and gen-

























































































































Figure 4.15: High level system with 18 states and M0hi = [3,5,1].
4.3 Control Consistency
The main goal for the development of the abstract model was to avoid working on the low-
level model directly. Therefor Ghi is the model that will be analyzed for the control design.
However the ultimate control implementation will have to be in terms of individual protein
interactions which is a language only recognized by Glo. Some earlier work has been done
on the subject of consistency in supervisory control of hierarchical models [122], however
no research has been done on the subject of consistency in multi-layer non-hierarchical
systems.
While the control specification (i.e. desired cell dynamics) is presented in terms of
L(Ghi) (i.e. sequence of pathway activations), in order to be able to implement the control
law on Glo it is necessary to find at least one ti ∈ Tlo for each controllable l j ∈ Thi such that
disabling ti will disable l j and only l j. Therefore, there should be at least one vi ∈ Prehi(l j)
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where Mhi(vi)< Fhi(vi, l j) can be achieved, by disabling ti. That is for all si ∈ ℓ(Glo) such
that C(L(ti),si) = 0, where C(σ ,S) counts the number of σ ’s in S, vi should be bounded in
Gmi and Mmi(vi) < Fhi(vi, t j). The development of control strategies for cell dynamics, is
the motivation for the next chapter. This development is the subject for future work.
This condition will guarantee that, when the high-level controller is disabling an
action, the control command can actually be implemented in the system.
4.4 Conclusion
In the post genomic era, the most important area of research in systems biology is to design
suitable models and tools that can efficiently use the available knowledge and come up with
useful observations and decisions for treatment of various diseases. Modelling the cell as
a discrete event system helps reduce the complexity of the analysis and synthesis (control)
problems, while capturing the essential knowledge. However, due to many factors such as
the size of the problem and the uncertainty in the knowledge, the existing techniques for the
study of discrete-event system need to be extended. In this chapter, a method is presented
to verify whether an abstract model can replace a large low-level model (for the purpose of
studying pathway sequences) by checking a modelling consistency property. These models
may be used for developing control strategies for altering cell dynamics.
64
Chapter 5
An Efficient Framework for Sensitivity
Analysis in Petri Net Representation of
Biological Systems
Emergence of knowledge-intensive models in various different fields such as finance, so-
ciology and biology has resulted in new challenges for modelling, analysis and control of
such data-driven systems. The complexity and size of such systems are unprecedented and
requires new tools and frameworks. In particular, new drug design, diagnosis and progno-
sis of disease in biological systems is a subject of research that can well be studied using
methodologies in control theory. In this chapter sensitivity analysis in a Petri net represen-
tation of biological systems is studied. A theory is developed for efficient calculation of a
rigidity measure as an indication of sensitivity. The proposed method is refined to avoid
reachability analysis as much as possible in order to be computationally efficient. It is also
shown using simulation that the measure accurately achieves identifying the best candidate
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for drug design target in a real example of Caspase cascade as part of Apoptosis pathway.
5.1 Introduction
Systems biology is a growing inter-disciplinary field of study that focuses on the complex
interactions within biological systems. One of the main concerns of systems biology is
to discover how such interactions function and affect the behaviour of biological systems
(e.g. enzymes in metabolic networks) by using theoretical, analytical or computational
modelling tools. The goal is to propose specific testable hypotheses about a biological
system, validate them experimentally, and then refine the computational model or theory.
With such a goal, various experimental and analysis techniques from different disciplines
are employed to advance the research in systems biology [52, 57, 123].
One of the main focuses of systems biology concentrates on modelling protein path-
ways and using systems theories and tools to study the emergent behaviour and properties
of such pathways. Petri nets are one of the powerful mathematical modelling languages
that are widely used for studying biological pathways due to their graph-based structure
and the fact that they allow formal and transparent representation of the system based on
their firm mathematical foundation. One of the reasons that makes Petri nets popular in
systems biology is that they provide a balance between modelling power and analyzability:
many properties can be automatically determined for Petri nets, some of which are very ex-
pensive to determine in the general cases, such as reachability, boundedness and liveness.
[16, 44, 50, 51, 113].
Biological models do not necessarily provide a straightforward understanding of the
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relationship between input (the variable whose change leads to a change in another de-
pendent variable, i.e. the output) and output (the dependent variable) of the model due to
the complexity of their structures. Understanding how the model behaves in response to
changes in its inputs is of fundamental importance [124]. One of the important tools used
in analysis and design optimization of a system is sensitivity analysis. Sensitivity analysis
is defined as how changes in the output of a model (system) can be affected by changes in
inputs of the model. [49, 57, 125].
Considering the importance of biological processes such as Apoptosis, it is of great
value to model and analyze their underlying pathways and try to understand the behaviours
that arise from the structural properties of such pathways. This information can later be
used in design of control mechanisms with the aim of finding drugs to regulate the be-
haviour of these processes.
A central aim of systems biology is to study the complex dynamic structure of bio-
logical systems. One of the main endeavours in this area is to construct models and theories
that are dynamically explanatory, rather than purely descriptive. It is the intention of this
thesis to propose a method to enable calculating the sensitivity of a specific quantity of a
biological network regarded as the output of the system to other different parameters of the
network regarded as inputs of the system. Using this information, one might be able to
design a control mechanism to influence the behaviour of the system using the input that
has the highest effect on the output.
The main concerns in choosing a method for computing sensitivities are its accuracy,
computational expense, and ease of implementation [126] .
In this research, Petri net modelling framework has been used to calculate a sen-
sitivity measure for biological systems. The rest of this chapter is organized as follows.
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The proposed sensitivity measure and the logic behind it, is introduced in section 5.2. The
computational results corresponding to the application of sensitivity analysis to the Apop-
totic pathway is presented and compared with previous results in section 5.3. Finally, in
section 5.4, the chapter concludes by a summary of the points and an outlook on future
research directions.
5.2 Sensitivity
One of the main questions that needs to be answered after providing a Petri net model for a
biological system, is how would it be possible to influence the system to achieve a desired
behaviour. In other words how can a control strategy be implemented. In order to answer
this question, it is necessary to first define inputs and outputs so that control objective can
be described.
The biological systems are naturally stable systems. States are always bounded, and
multiple feedback loops regulate the whole system and ensure that biological entities main-
tain homeostasis. In case of a malfunction of one or a series of such regulatory mechanisms
a disease occurs, which would require a certain drug to force the system back to the normal
behaviour.
In order to help design such drug, it is required to know what node in the protein
network can have a higher influence on the desired output protein or proteins. Hence the
input and outputs of the system will be proteins or places in the Petri net model. The
question of a better influence translates into a sensitivity analysis in such networks. The
researcher would like to know that perturbing which protein can result in a better outcome
in the desired output protein concentration. This will offer a possible target or targets for
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drug design.
In the example studied here, it is desired to control the rate of Caspase cascade. More
precisely the activation rate of the cascade must be kept in healthy levels by controlling the
rate of its consumption. Therefore the problem is to find which molecule in the network
influences casp3 or casp3* the most. That protein will be the target of drug design. This
drug will control the Caspase cascade and hence satisfy the control objective. Note that the
design of the controller is a completely different task. For the purpose of this research, sen-
sitivity is defined as the range over which the tokens representing a protein would fluctuate
given certain excitation at the initial condition at which the Petri net starts. Note that this
measure is relative, so for each desired output, the measure depends on which places in the
initial condition are excited.
Starting from any given initial condition M0, the Petri net G will create a reachability
set such as RG(M0). The desired output po will have different token values at different states
in RG(M0). Suppose that a counter is observing these values, and each time po reaches a
value j, it adds one to the count of value j.
Definition 9. V (M0, po) or V M0po is a vector [v0, ...,vk], where v j is the number of times po
has j tokens starting from the initial condition M0, and is called the frequency vector or
signal of output po.
Definition 9 provides a count on distinct values of the number of tokens in place po
representing some protein A in RG(M0). If a change in the initial condition to M′0 would
have little effect on the desired output place, then in the reachability graph, there will be
many states with the same value for the output, and V M0po and V
M′0
po would be very similar.
This will result in a narrow frequency vector, (i.e. V M0po will have few very large elements




































Figure 5.1: Part of Apoptosis pathway, and drug delivery mechanism.
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desirable that the frequencies would be distributed more widely or with a larger variance,
which would mean the input has had a better influence on the output. While a uniform
distribution of frequencies shows that the output has changed more often, a narrow distri-
bution would mean that changes in the input have not resulted into output changes, (i.e. the
output has stayed unchanged). For simplicity use V (l) as the l-th element of vector V M0po ,
also V (M0, po)>V (M′0, po) when M0 results in at least as many elements in the frequency
vector as M′0, and the amplitude of each frequency is higher.
Definition 10. ρ(M0, po) called the rigidity measure of a place po, is calculated as the l2-
norm of the vector V M0po , which is the frequency of the token numbers in the place po when
the initial condition is M0.
Using Definition 10 it is possible to drive a measure on how perturbance in the initial
value of an input place would result in changes at the given output place. A lower rigidity
measure means that the perturbed input has a better influence on the output and therefore
is a better target (i.e. more sensitive) for control purposes.
Given an initial marking M0, Petri net G can generate a reachability set RG(M0). If
M′0 is obtained by adding a single token in a place p j in M0, then RG(M
′
0) will either have
the same size as RG(M0) or have more elements. It can not shrink as the dynamics of the
Petri net is not blocked by more tokens. Hence V (M′0, po) = V (M0, po)+ δ , where δ ≥ 0
is the change in frequency.
Case 1: (δ = 0) If RG(M0) would have the same size as RG(M′0), the conclusion is that,
the chosen input place is saturated and can no more use extra tokens, hence some
tokens will never leave that place.
Case 2: (δ > 0) If the size of RG(M0) grows as a result of new tokens, then the conclusion
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is that, new states have been created.
Definition 11. For a given initial condition M0 and desired input place pi, saturation limit
Ms0(pi) is the maximum number of tokens before pi will be saturated.
If the number of tokens in a place pi are less than Ms0(pi), then all tokens in pi will
eventually be consumed.
Definition 12. RG(M0), the reachability set of Petri net G starting from initial condition
M0 has a deeper reach than RG(M′0) and is written as RG(M0)≥ RG(M′0) when there exists
a one to one map τ from RG(M′0) to a subset of RG(M0) in which for every M
′ ∈ RG(M′0)
there exists an M ∈ RG(M0) with M′ ≤M element-wise.
Definition 12 implies that if RG(M0) ≥ RG(M′0) then for every reachable state M′ in
RG(M′0) there exists a similar reachable state M in RG(M0) in which all enabled transitions
in M′ can fire.
In order to achieve sensitivity analysis using the rigidity measure the following algo-
rithm has to be used.
Algorithm 3. Given a Petri net G, output place po and a set of inputs P= {P1, ...,Pk}, find
a place pi ∈ P, such that po is least rigid (i.e. most sensitive) to pi.
Step 1. Choose an initial condition M0, also choose a sufficiently large M = M0+∆M as
an upper bound for the initial condition. Choose j = 1, and set Mt = M0.
Step 2. Calculate the reachability graph RG(Mt).
Step 3. Calculate V Mtpo , the frequency of output, and take an l
2-norm, to find the rigidity
measure ρ(Mt , po), save this value in a set S.
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Step 4. If Mt <M add one token to the j-th place in Mt and go to step 2.
Step 5. If j < k, then set j = j+1, Mt = M0 and go to step 4, Otherwise go to step 6.
Step 6. Using S, the set of rigidity measures for each input in P, find the index i representing
smallest values. pi ∈ P is the desired place.
Remark 6. The upper bound M in step 1 of algorithm 3 can be chosen arbitrarily large,
as long as each element in M is larger than the largest element of M0, so all elements
of ∆M are positive and non zero. Also no place should be saturated, meaning that the
newly added token should be consumed. Ideally this range should result in enough points
for comparison of all rigidity measures. Note that usually sensitivity is studied in a small
neighbourhood of operating point.
As can be observed from algorithm 3 in order to calculate this measure, first the
reachability set for Petri net has to be calculated. A breadth-first search (BFS) method can
be used that finds a list of all possible transition firings and fires them all, and adds all the
new states to the reachability set, and the process is repeated until no new states can be
constructed. Note that there are other algorithms that could be more efficient than BFS,
however the performance should be evaluated based on each specific case.
In general the calculation of the reachability set is very time consuming and expo-
nentially complex. Furthermore this algorithm requires that this calculation be repeated
many times, to find the best target. Therefore it is desired to find a better solution for the
sensitivity analysis.
Lemma 1. If M′0 ≤ M0 then ρ(M′0, po) ≤ ρ(M0, po). The Petri net rigidity measure of a
given output place for an input as defined in Definition 10 is strictly increasing with respect
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to the initial condition.
Proof: By assumption M′0 is coverable by M0, then RG(M0) has a deeper reach than RG(M
′
0),
or RG(M0) ≥ RG(M′0). Therefore V (M0, po) ≥ V (M′0, po), in other words the number of
times that the Petri net visits a certain state would only increase as the initial condition
increases. Since the rigidity measure is an l2-norm of the frequency of the output at a given
place (i.e. output) therefore the rigidity measure is a monotonically increasing function
with respect to the initial condition.
P1 P2 P3 P4
Figure 5.2: Petri net with 4 places, P3 is assumed to be the output.
Once it is shown that the rigidity measure will only increase with respect to initial
condition (as results are shown in figure 5.4 for a simple example depicted in figure 5.2), it
is desired to know if the rate at which it increases has a specific behaviour. The following
assumptions will be used to clarify the process of proof, however they can be easily relaxed
as will be shown later.
The Petri net model is trying to capture all possible combinations of proteins and
produce a reachability set that is covering as many states as possible. However when the
norm of the initial condition (e.g. infinity norm or l2-norm) is smaller than some D it is
possible that the network would get blocked by lack of tokens, and hence the reachability































Figure 5.3: Rigidity measure for the system depicted in Figure 5.2.
to assume that there are enough tokens in the net initially that would result in a system
which can exhibit all possible behaviour.
Assumption 3. For any E > 0 there exists a D > 0 for which, if the l2-norm of the initial
condition is larger than D then all transitions in the system can fire more than E times.
Assumption 3 says that our system shows a rather smooth behaviour, and that all
transitions get to fire enough, to demonstrate the full dynamic range of the system.
Remark 7. In modelling biological systems, it is known that the system will not exhibit
unbounded behaviour. Furthermore, the system is globally fair. It can also be assumed that
the weight of all arcs are equal to one. Firstly the chemical reactions of Caspase cascade
in Apoptosis will result in such weights, and secondly even if a system results in larger
weights for arcs, without loss of generality the framework presented here can be expanded
to cover those cases.
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Figure 5.4: Rigidity measure calculated for a linear Petri net with four places shown in
Figure 5.2, P3 is assumed to be the output.
In order to be able to compare rigidity of an output po with respect to two different
input places p1 and p2, it is also necessary that the two measures would have same origin
so that they are comparable. In other words the initial condition at p1 and p2 has to be the
same.
Assumption 4. For comparing rigidity measures of p1 and p2 the reachability set is cal-
culated starting from the same initial condition M0.
It follows immediately from Assumption 4 that the reachability set for two initial
conditions in p1 and p2 is equal initially and hence the rigidity measure is equal at the first
point.
We further assume that the two places to compare have different structural signifi-
cance on the output and hence different sensitivities.
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Assumption 5. The subnets starting from either of the two places p1 and p2 and ending
in the output place po are structurally such that, equal perturbation in p1 and p2 results in
different rigidity measures at po.
Assumption 5 requires that neither the subnets from p1 and p2 to po would be iso-
morphic by a mapping of transition and place names, nor any abstracted versions of them
be isomorphic. As a result they will have different sensitivities. It is now possible to prove
the second lemma, that the two rigidity measure signals which are always increasing and
smooth are not going to cross in a point other than their initial condition.
Assumption 6. The system being studied does not have any sources of new tokens and no
sinks. Furthermore the biological systems are naturally bounded.
Assumption 7. When comparing sensitivity of p1 and p2, if all initial tokens in p1 or p2
are consumed, and the number of tokens reaches zero, it will not go to one again.
Lemma 2. For every sequence s, where Mk+1
s−→ M′k+1 and Mk+1(pi) = Mk(pi)+ 1 > 0
and M′k+1(pi) = 0, there exists an equivalent state in RG(Mk+1) which does not exist in
RG(Mk)
Proof: If a sequence such as s= {s1,s2, · · · ,s j} would take Mk+1(pi) to zero, it means that
at least one si consumes the last token in pi, which is impossible when the initial marking
at pi has one less token.
Lemma 3. The frequency changes of the output with respect to the changes in the input
can be calculated and is only dependant on the structure of the Petri net.
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Proof: In Petri net G, using the state equation M′ = M+Ax will result in A[i]x = M′[i]−
M[i], where the i index represents the i-th row of the matrix. Suppose that M′[i] = 0, which
means, the solutions {x j} of the state equation which are different firing sequences, will
result in all tokens in the input place to be consumed, hence according to Lemma 2 creating





condition Mk has been used and Mk+1 has been obtained by adding one token to place





where A(pi) is a vector equal to the row in matrix A that corresponds to place pi. The
diophantine equation 5.1 can have many solutions. Let X pik+1 = {x¯} be the set of all such
solutions. Now for X pik and X
pi






x′ can be written as x1+ x2, where x1 = x and A(pi)(x1+ x2) =−mk−1, hence
A[pi]x2 =−1 (5.3)
Now suppose that the row corresponding to the output or A(po) is used to calculate the






Calculating the frequencies, knowing that with slight abuse of notation V (Mk+1, p0) =
V (Mk, p0)+δk,
δk+1 = δk +δ ′
= δ0+ kδ ′
(5.5)

















Lemma 4. For a given common output po the rigidity measure for increasing initial con-
ditions smaller than the saturation limit at p1 and p2 will only be equal when the initial
conditions are equal.
Proof: Following Assumption 4 it is known that the two rigidity measures for p1 and p2
are equal at the initial condition M0. Suppose that one token is added once to p1 and once
to p2, to arrive at M11 and M
2
1 for calculating the rigidity measure at p1 and p2 respectively.
Assumption 5 will result that the rigidity measures at M11 and M
2
1 are not equal. Without
loss of generality, assume that the rigidity calculated for p1 is smaller than p2. In order to
use strong induction, assume that for a given k, M1k and M
2
k are the initial conditions for p1
and p2, obtained by adding k tokens to p1 and p2 respectively in M0, and that the rigidity
calculated at p1 is smaller than p2. It is now desired to show that the relationship will hold
at k+1 as well, and therefore the two signals will never cross again after M0.








∃ci > 0 such that, l2(V Mk+1Po )≤ ci.l2(V
Mk
Po ). (5.8)
The positive constant ci is called the rigidity norm. Using equation 5.7 and 5.8, the
rigidity norm can be calculated, and for each input-output pair would be among a set of
constants.
Since the behaviour of the system is smooth and it is already known that the rigidity
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at p1 is smaller than in p2, adding one token to p1 and p2 will preserve the order of the
rigidity measures.
Remark 8. Note that using Lemma 3 one can calculate the rigidity measure without the
need of extensive reachability analysis.
Now that it is shown the two rigidity measures are only increasing and after initial
condition will never cross again, it can be concluded that for the purpose of identifying
the most sensitive place among a given set of places, it is not necessary to calculate the
rigidity measure at all points, it suffices to calculate at one single point that satisfies the
assumptions. Therefore it is not necessary to calculate the reachability graph at different
initial conditions.
Theorem 2. Given a set P = {p1, p2} of places, in order to find the most sensitive place
with respect to a place po it is sufficient to calculate the rigidity measure at M1k and M
2
k such
that M1(p1) = k, M2(p2) = k and M1(p2) = M2(p1) = 1, where k satisfies assumption 3.
Proof: The proof follows from Lemma 1 and Lemma 4.
It is obvious from Theorem 2 that for any given set of places with more than two
members, the same deduction can be obtained.
Remark 9. If Assumption 3 does not hold, it means that there are parts of the system
that are blocked by lack of tokens, as long as the output place is not among the blocked
places, one can assume that the Petri net does not have those places. Also assumption 4
does not really pose a limitation on the system, it only provides a framework to calculate
and compare the measure. Regarding assumption 5, if there exists an exact isomorphism
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between all possible paths from two input places to the desired output place, then their
rigidity will be equal.
Using the proposed measure is useful for sensitivity analysis, however there are two
factors that need to be considered. First, it would be interesting to use various other func-
tions or norms to achieve different measures other than sensitivity as presented here. Sec-
ond, It is desirable to further reduce the need to calculate reachability graph at a single
point k. In the main example studied here (Example 6), for which the simulation results
are presented in section 5.3, the reachability graph will exceed 74000 states, even using
relatively small initial conditions. Therefore a more efficient and flexible approach would
be very useful. In the rest of this section, a method is proposed to calculate rigidity with
less computational expense.
Definition 13. The frequency difference from lk to lk−1 for k = 1,2, · · · is defined as,





Assumption 8. The random variables V M0Po (l1), V
M0
Po (l1, l2), V
M0
Po (l2) are mutually indepen-
dent for any l1 < l2
Assumption 9. P[V M0Po (lk−1, lk) = n], for n = 0,1, · · · may depend on the interval length
(lk−1, lk), but it is independent of lk−1 and lk for any, k = 1,2, · · · .
Definition 14. Pi(l) is the probability that the output place of the Petri net G(M0) would
have l tokens, exactly i times in its reachability graph.
Definition 14 can be written as,
Pi(l)≡ P[V M0Po (l) = i]. (5.10)
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By definition take P0(0) = 1, also since tokens arrive only on integer values, for any
h< 1, it can be seen that P0(h) = 1.
Lemma 5. For any sufficiently small h and for Petri net G with assumption 3 it can be
written P0(t+h) = P0(t).P0(h).
Proof: By definition,
P0(t+h)≡ P[V M0Po (t+h) = 0]




Po (t, t+h) = 0]
V (l)≥0−→ = P[V M0Po (t) = 0∩V
M0
Po (t, t+h) = 0]
Assumption 9−→ = P[V M0Po (t) = 0∩V
M0
Po (0,h) = 0]




Po (0) = 0]
P0(0)=1−→ = P[V M0Po (t) = 0].P[V
M0
Po (h) = 0]
= P0(t).P0(h).
(5.11)
Lemma 6. The probability of first token arrival is exponentially distributed.
Proof: Assume that P1(h) is differentiable at h = 0, and the derivative is a positive value
such as λ ,
P′1(0) = λ (5.12)
Having P≥2(h) = ∑∞i=2 Pi(h), since P is a probability distribution and also since the tokens
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Taking a very small h equation 5.14 will lead, P′0(t) = −λP0(t), which can be solved and
will result in P0(t) = e−λ t
Theorem 3. The frequency vector as defined in definition 9 follows a Poisson distribution.
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Proof: The proof follows from Lemma 5 and Lemma 6. From lemma 5, and using poly-
nomial expansion of the exponential, it follows that,





P[V M0Po (t, t+h) = n− j∩V
M0





P[V M0Po (t, t+h) = n− j].P[V
M0





P[V M0Po (h) = n− j].P[V
M0
Po (t) = j]
=P[V M0Po (h) = 0].P[V
M0
Po (t) = n]
+P[V M0Po (h) = 1].P[V
M0





P[V M0Po (h) = n− j].P[V
M0
Po (t) = j]
≃(1−λh)P[V M0Po (t) = n]+λhP[V
M0










P1(t) = (λ t)e−λ t (5.17)







Now that V M0Po is known to follow Poisson, the rigidity measure can be defined as
higher moments of V M0Po and hence obtained without having to calculate the reachability
tree. The rigidity norm ci therefore would be calculated from the probability distribution
function.
Remark 10. The biological nature of the system being studied guarantees that assump-
tions 8 and 9 are satisfied.
Definition 15. σM0Po called the refined rigidity measure of a protein po, is calculated as the
second moment around the mean for the distribution of V M0Po , which is the frequency of the
tokens in the place po when the initial condition is M0.
The moment will be calculated using






= λ t (5.19)
In order to achieve sensitivity analysis using the refined measure the following algo-
rithm is used.
Algorithm 4. Given a Petri net G, output place po and set of inputs P= {P1, ...,Pk} find a
place Pi ∈ P, such that po is most sensitive to Pi.
Step 1. Choose an initial condition M0, also choose m>max(M0). Choose j = 1.
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Step 2. For each Pj ∈ P, substitute the corresponding element in M0 with m, and go to
step 3.
Step 3. Generate partial reachability for G(R0), and estimate mean λˆ j by fitting a poisson
distribution to the data.
Step 4. Using λˆ j, calculate the second moment as c j and save it in S.
Step 5. If every P ∈ P has been used go to next step, otherwise go to step 2.
Step 6. Using S, the set of rigidity measures for each input in P, find the index i representing
smallest values. Pi ∈ P is the desired place.
Remark 11. Step 3 of algorithm 4 needs just enough data to be able to estimate the mean
of a poisson distribution. Since Poisson does not depend on the where the sample is taken,
the sampling can be taken very easily.
Remark 12. As can be observed algorithm 4 is much more efficient than algorithm 3. First
it does not repeat the calculation for multiple points, and second, as it does not require full
reachability analysis. As shown in the simulations it will yield in similar results.
Remark 13. In any application where assumption 8 or 9 would not hold and hence the
Poisson distribution could not be used, still the appraoch used in algorithm 4 could be
used by estimating the mean of the appropriate distribution.
5.3 Simulation
The theoretical results of section 5.2 are first validated using a simple artificial example.
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Example 5. Suppose that a simple Petri net with three places is given as shown in Fig-
ure 5.6, and P3 is the output, where sensitivity to other elements needs to be studied. Start-




, the initial conditions of each
place is changed from 1 to 11, and rigidity measure is calculated for each point. As can be
seen in Figure 5.7, P2 has a lower rigidity measure than P1 and therefore is a better target
to influence P3 levels, which is also expected since it can be observed that P1 is farther to
the output P3, furthermore the measure does not change at P3 since all tokens are finally
deposited at P3 and when the initial condition is perturbed at P3 no new behaviour will be
observed. Figure 5.8 shows the results for both Algorithm 3 on the right and 4 on the left.
It can be observed that the results here are not consistent. This is due to the fact that place
P1 is depleted from tokens without any source and hence does not satisfy the condition of
the assumption 8. As the network gets more complex, it can be seen that the two algorithms
will provide the same results, except at the input place P1.
Suppose that another place is added to the Petri net, such as P4 in Figure 5.9, notice that
P1 P2 P3
Figure 5.6: Petri net example with three places
P4 is creating a parallel path and it’s consumption is also regulating P3. The simulation is
now repeated for different initial conditions, and the resulting rigidity measures are shown
in Figure 5.10.
As expected P4 has the lowest rigidity measure and hence the best target to influence the
output in P3. Note that the rigidity measure for P3 is still the lowest (i.e. highest influence
88






















































Figure 5.8: rigidity with three places
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on itself) however since the tokens are being consumed by a transition, it does not stay
constant.
The results of the two algorithms is shown in Figure 5.11, where Algorithm 3 is on the
P1 P2 P3
P4
Figure 5.9: Petri net example with four places
right and Algorithm 4 is on the left. The results are exactly as expected, where P4 has the
lowest rigidity and P1 which does not satisfy the condition does not stay consistent.
Next a new place P5 is added, and the transitions create a backward loop in the structure
of the system, as depicted in Figure 5.12.
The initial conditions are changed as before and the results of rigidity measure is shown
in Figure 5.13, As can be observed from Figure 5.13, P4 has the lowest rigidity. The results
of Algorithm 3 and 4 are shown in Figure 5.14.
Next the Theorem 2 is verified using the Caspase cascade pathway as introduced in
Chapter 2, also the results match those of the continuous analysis done using SimBiology
in MATLAB [28].
Example 6. In the Caspase cascade as one of the most important parts of Apoptosis path-
way it is desired to identify the best drug target that would influence the casp3* concentra-
tions. The continuous analysis done in MATLAB verifies that XIAP is the best choice. The
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Figure 5.11: rigidity with four places
P1 P2 P3
P4P5
Figure 5.12: Petri net example with five places and loop.
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Figure 5.13: output rigidity measure for 5 places with loop.
























Figure 5.14: rigidity with five places.
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Petri net of the model is constructed as depicted in Figure 5.1. The initial conditions are
then perturbed for various molecules in the network and the rigidity measure is calculated
as shown in Figure 5.15.
As can be observed the lowest rigidity measure belongs to XIAP, which matches the actual































Figure 5.15: Caspase cascade rigidity measures.
results in the biology literature [77] as well as continuous sensitivity analysis in SimBiol-
ogy tool for MATLAB, as seen in Figure 5.16, where XIAP has the highest sensitivity and
Casp 8 has the lowest, which matches the results obtained from Petri net analysis. Note
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that the definition of sensitivity used here is not exactly replicating that of SimBiology and
hence does not result in exact same values.
Figure 5.17 shows the results of the Algorithm 3, where XIAP has the lowest rigidity.



















Sensitivity ï Time Integral
Figure 5.16: Sensitivity calculated using continuous model with SimBiology in MATLAB
Figure 5.19 depicts the results of Algorithm 4, XIAP still has the lowest value, and the
order of all places is also the same. Note that as expected all rigidity measures are equal
at the point in which the initial conditions have been equal. Figure 5.20 shows the output
distribution for six different proteins in the network, the x axis represents the number of
tokens in the output protein, while the y axis is the number of times at which that value
has been observed. Multiple lines show increasing values on initial condition in respective
molecule.
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Figure 5.17: Rigidity for apoptosis calculated using Algorithm 3















Figure 5.18: Refined rigidity for apoptosis calculated using Algorithm 4 with maximum
5000 states calculated in reachability
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Figure 5.19: Refined rigidity for apoptosis calculated using poisson estimates on full reach-
ability


















































































































Figure 5.20: Distribution of different outputs
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5.4 Conclusion
Knowledge-intensive systems such as biological systems are the new frontiers of research
for engineers, who wish to bring the power of their tools to the modern problems that have
been formed due to huge amounts of data generated each day. Discrete modelling using
Petri nets has been proposed for biological systems, however control analysis for such
systems requires new tools. In this work a framework has been proposed for efficiently
calculating sensitivity of a desired output with respect to different protein concentrations.
It is shown using a simple example as well as a real biological example that the measure
introduced can accurately identify the desired targets. The mathematical proof is provided
to show that sensitivity analysis can be done without structural analysis of the Petri net and
by looking at the behaviour of the Petri net for various initial conditions. It would be inter-
esting to study the rigidity norm as defined in this work, which could help relate the same
sensitivity analysis directly to the structure of the Petri net. Also for different applications
one might be interested in defining other norms than l2-norm, such as a weighted norm,
which would put more emphasis on certain values of the output. This could be regarded as




Conclusions and Future Work
6.1 Conclusions
The use of discrete event modelling tools for analysis of biological systems has been studied
in this thesis. The first goal is to establish a useful framework in capturing the knowledge of
such systems using Petri nets. As a result of the size and inherent complexity of the system,
a mechanism is introduced for consistency analysis between Petri nets obtained from two
knowledge sources. This framework can be very well applied to other knowledge-intensive
systems such as financial systems or social systems.
A case study is conducted to demonstrate the performance and success of the frame-
work. The next goal is to develop tools and measures necessary for designing a control
strategy which in the case of biological systems would translate to drug design. In order to
achieve such analysis, a measure for the rigidity of the Petri net places is defined that can
be used for identifying the proteins to which a desired output is most sensitive.
Sensitivity analysis of the petri net will help identify the best candidates for designing
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a drug to alter cell behaviour (i.e. control cell dynamics). It is shown that it is possible to
define and evaluate a rigidity measure without the need for extensive reachability analysis
on various initial markings. These models may be used for developing and implementing
control strategies for altering cell dynamics.
The results of this analysis are then compared with the similar results obtained from
the continuous model as performed in the SimBiology library of MATLAB. The proposed
algorithm based on the discrete-event model results in the same identification of protein as
in the continuous case.
With the rapid generation of data in various systems, the challenges are growing
faster than ever to develop and utilize methods and frameworks that can efficiently and
effectively analyze such systems, while this thesis does not find a cure for cancer, it can be
regarded as an step towards such modelling frameworks.
6.2 Future research
This area of research is very new and has a lot of interesting subjects that can be studied.
Some of the immediate topics that will follow this work include the study of quantization
effect on consistency and sensitivity. The choice of quantization of protein concentrations
will inevitably have an effect on the dynamics of the system. As a quantization function is
used to assign discrete tokens to each place of the Petri net. It is interesting to study effects
of different quantization methods.
Also when calculating the sensitivity measure, the focus of this work has been on l2-
norm, however depending on the application one could use weighted norms which would
assign more weights to certain places.
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The problem of sensitivity can also be studied in the framework of consistency. This
would mean that the sensitivity at a high level model would be equivalent to the sensitivity
for the low level model under certain conditions.
Similar to the methodology used for modelling consistency, a measure can be devel-
oped that would describe the control consistency of the two models. A refinement algorithm
can then iterate on the model to create other possibilities for the control to be implemented.
Eventually the algorithm will create a controllable language, based on the biological con-
straints on disabling events.
It is also desirable to see how the Assumption 1 and Assumption 2 can be relaxed,
and what would be their impact on the general notion of consistency between the high-level
and low-level models.
In the supervisory control of discrete event systems, it is normal to assume, that the
alphabet of the system is divided into two disjoint sets, of controllable and uncontrollable
events, and the supervisor would have the capacity to disable any controllable events at any
time, without changing the nature of the events. In biological systems, the definitions of
controllable and uncontrollable events will be different. While it is still true that some of the
events can be disabled by increasing concentrations of other proteins, yet some events can
be facilitated by such increase. Enabling or disabling of one event can potentially change
the controllability of some other events. Also excessive increase in certain concentrations
can have variable effect on disabling of events.
Mutations of different genes, can result in different sets of responses in the system.
Two mutations are synthetically lethal if cells with either of the single mutations are viable
but cells with both mutations are inviable. In other words, it is not just a single event that
needs to be disabled but a string needs to be disabled in order for a certain behaviour to
101
appear.
Furthermore, it is possible to force some of the events to happen while, a supervisor
will only have the capacity of disabling events not triggering them. Hence, the control de-
sign will be different from the conventional Ramadge-Wonham supervisory control design.
These issues could be subject of future studies.
Finally the study of supervisory control of Petri nets should be applied to the models
of biological systems, using the framework developed in this thesis.
A control strategy that is designed based on the high-level (pathway level) model
will be implemented on the low-level (protein interaction) model. The designed supervisor
(controller) could essentially be an autonomous molecular computer [127] that would be
used for anti-viral therapies, in which systematic gene delivery is applied to target and kill
metastases is applied using genetically modified viruses or stem cells [23]. As a topic for
future work, it would be interesting to consider uncertainty in the model and also investigate
some combination of linear and discrete behaviour as a hybrid model.
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A.1.1 Connecting to the KEGG API Web Service
The following sample code can be used to connect to the KEGG web service API. the
WSDL located at ’http://soap.genome.jp/KEGG.wsdl’ is an XML that defines the parame-







% You can confirm that kegg is an instance of the KEGG using the *class* com
mand classType = class(kegg)
kegg_ids_conv = bconv(kegg, ’ncbi-gi:10047086 ncbi-geneid:14751’)
organisms = list_organisms(kegg)
homo = organisms(1)
pathway_list = list_pathways(kegg, homo.entry_id);
num_pathways = length(pathway_list)
aemp_pathway = pathway_list(17)




aemp_enzymes = get_enzymes_by_pathway(kegg, aemp_pathway.entry_id);
num_enzymes = length(aemp_enzymes)
aemp_reactions = get_reactions_by_pathway(kegg, aemp_pathway.entry_id);
num_reactions = length(aemp_reactions)




obj_list = [aemp_genes(5:6); {’hsa:83875’}; aemp_compounds(2); aemp_com
pounds(32:33)]; fg_list = {’#ff6600’, ’#0000ff’, ’#0000ff’, ’#0000ff’,
’#ff0000’, ’#ff 0000’}; bg_list = {’#99ccff’, ’yellow’, ’#ff6633’,









hfig = figure(’Colormap’, cmap);
hax = axes(’Parent’, hfig);
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himg = image(x, ’Parent’, hax);
set(hax, ’Visible’, ’off’) scaleimagefigure(hfig, hax, himg);
A.1.2 Petri net Reachability
The following sample code takes three inputs. Pre is the matrix representing the inbound
arc weights, and Post is the matrix of outbound arc weights. Together these two matrices
define the structure of the Petri net. Vector M0 is the initial marking for the Petri net. The
outputs of the code are the adjacency matrix, which defines all possible firings, as well as
RM, which is the list of reachable markings. This code can be used for converting the Petri
net into a generator.
function [A,RM] = reachability(Pre,Post,M0)
% function reachability finds a graph of reachable markings
% to given marked bounded Petri Net
% A - Adjacency matrix
% (A(i,j) means oriented arc from vertex i to vertex j)
% value of A(i,j) means index of fired transition
% RM - Matrix of reachable states







while i < size(RM,2) && i < 2500
%main loop
%while (number of already inspected states)<(number of existing states)
i=i+1;
%generation of vector of enabled transitions
for k=1:noft















if any(v) %state already exists
A(i,j)= fx(k);
else %state does not exist
RM=[RM,bb];
A(size(A,1)+1,size(A,2)+1)=0;
A(i,size(A,2))=fx(k);
end;
end;
end %main loop
max(RM(2,:))
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